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Abstract 
Insights into cardiac remodelling by multi-modal magnetic resonance 
imaging and spectroscopy 
Steffen E. Petersen, Christ Church, DPhil, Trinity Term, 2005 
Cardiac remodelling, defined as a change in cardiac shape and size in 
response to myocardial injury or external stimuli (pressure- or volume-
overload), can be physiological or pathological in nature. Physiological 
remodelling may occur in athletes and pathological left ventricular hypertrophy 
can be found in hypertrophic and dilated cardiomyopathy, in left ventricular 
non-compaction (LVNC) and in left ventricular hypertrophy secondary to 
hypertension or aortic stenosis. Cardiovascular magnetic resonance (CMR) 
allows for detailed characterisation of structural and functional cardiac 
changes using imaging and spectroscopy techniques. 
This thesis aimed to achieve several goals: First, we aimed to establish 
normal databases for left and right ventricular volume studies, geometric 
cardiac indices, as well as three-dimensional contraction and relaxation 
patterns. Second, based on these, we aimed to establish CMR-specific 
diagnostic criteria for the differentiation of physiological and pathological left 
ventricular hypertrophy, and for the detection of LVNC. Third, in a cross-
sectional study of elite athletes and age-and sex-matched sedentary 
volunteers, we tested for sex-specific cardiac structural and functional 
changes to long-term exercise training. The final aim was to investigate 
cardiac energy metabolism in a group of LVNC patients with preserved 
cardiac function. It is unknown which pathophysiological mechanisms may be 
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responsible for the development of heart failure in this condition. One 
attractive mechanism which may explain progression into cardiac dysfunction 
in patients with LVNC may be altered cardiac high-energy phosphate 
metabolism since this has been described in hypertrophic and dilated 
cardiomyopathy. 
Healthy sedentary controls and volunteers with physiological (athletes) 
and patients with pathological cardiac remodelling (hypertrophic 
cardiomyopathy, left ventricular non-compaction and left ventricular 
hypertrophy secondary to aortic stenosis or hypertension) underwent steady 
state free precession cine imaging. Tissue phase mapping to assess three-
dimensional myocardial velocities was performed in sedentary controls and 
athletes. High-energy phosphates were determined by cardiac magnetic 
resonance spectroscopy in left ventricular non-compaction patients and in 
age- and sex-matched healthy controls. 
We established databases in healthy volunteers for cardiovascular 
magnetic resonance volume studies and systolic and diastolic myocardial 
velocities. Based on these databases, we were able to lend further evidence 
to the benign nature of athlete’s heart in demonstrating the absence of sex-
specific cardiac structural and functional differences due to long-term 
exercise. We found that athlete’s heart can be reliably distinguished from all 
forms of pathological cardiac hypertrophy using left ventricular volume and 
geometric indices, but pathological forms of left ventricular hypertrophy 
present with overlapping cardiac hypertrophy phenotypes. In addition to 
showing high diagnostic accuracy of cardiovascular magnetic resonance 
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imaging in left ventricular non-compaction, we demonstrated, for the first time, 
altered cardiac energetics in such patients at an early disease stage with 
maintained ejection fraction. 
In summary, we established normal ranges for cardiac volume studies 
and systolic and diastolic myocardial velocities using magnetic resonance 
imaging. We provided further evidence for the benign nature of athlete’s 
heart. MR-specific criteria for the differentiation of physiological from 
pathological LV (left ventricular) hypertrophy as well as for the diagnosis of 
left ventricular non-compaction were developed. Using MR spectroscopy, we 
documented reduced cardiac energy metabolism in left ventricular non-
compaction, which may contribute towards the development of heart failure in 
this condition. Multi-modal magnetic resonance allows new insights into 
chronic cardiac remodelling processes. 
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CHAPTER 1: Introduction 
1.1 Multi-modal magnetic resonance imaging and spectroscopy 
Magnetic resonance imaging (MRI) and spectroscopy (MRS) are 
based on complex physics. Bloch (Bloch, 1946) and Purcell (Purcell et al., 
1946) shared the Nobel Price in Physics for discovering the phenomenon of 
nuclear magnetic resonance. 30 years after describing the use of magnetic 
field gradients to encode for spatial distribution of nuclear spins, a paramount 
prerequisite for creating two- and three-dimensional images, Lauterbur and 
Mansfield were awarded the 2003 Nobel Price in Medicine (Lauterbur, 1973). 
Radda’s (Garlick et al., 1977) and Jacobus’ (Jacobus et al., 1977) groups 
were the first to record an MR signal from the heart, in the form of a 
31Phosphorus-spectrum. Cardiac MRI and MRS are challenging, as the heart 
is constantly moving due to breathing, cardiac contraction and relaxation. 
Major improvements in hardware (high-field, highly homogenous magnets, 
coil design, computing speed) and software, i.e. sequence development 
(steady-state free precession, SSFP), have contributed to the widely accepted 
role of CMR for growing numbers of clinical applications. This development 
has not come to a standstill and it is conceivable that CMR may become the 
primary diagnostic tool in cardiovascular medicine, due to its non-
invasiveness and versatility. 
1.1.1 Cardiac magnetic resonance imaging 
Nuclear spin is a property of atomic nuclei with an odd number of 
protons, neutrons or both, such as Hydrogen (1H), Phosphorus (31P) and 
Sodium (23Na) and Carbon (13C). Magnetic resonance imaging is commonly 
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based on the 1H nuclei of water and fat, which is the preferential atomic 
nucleus due to its high concentration in the human body (up to 110 Molar) 
coupled with its high “relative MR sensitivity”. 
Typical clinical MRI systems possess field strengths of 1.5 Tesla (T), 
which is about 20000 to 50000 times stronger than the earth’s magnetic field. 
Nuclei possessing net spin behave as minute radio-frequency receivers and 
transmitters in a magnetic field. The frequency ω0 of the transmitter is defined 
by the Larmor equation (ω0 = γB0; with γ being the gyromagnetic ratio and B0 
being the external magnetic field strength) and thus increases with increasing 
field strength. Radiofrequency (RF) pulses, if transmitted at the resonance 
frequency of the nuclei under investigation, elevate these spins to a higher 
energy level, from which they subsequently re-emit a RF signal on their return 
to the initial lower energy level. This re-emitted signal can be received and 
recorded. 
One valuable consequence of the Larmor equation is that protons 
transmit at slightly different frequencies, if they are exposed to different field 
strengths. By applying a linearly increasing magnetic field within the magnet, 
the location of the protons will be encoded within the re-emitted RF 
frequencies. The mathematical transformation from a sampled signal to the 
component frequencies is known as a Fourier transform and the amplitude of 
the signal at a specific frequency will represent the number of protons at that 
specific location. The direction of this gradient is described as the ‘read-out’ or 
‘frequency encoding’ direction in the MR image. To extend acquisition to two 
or more dimensions, additional switched magnetic field gradients (or gradients 
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for short) need to be applied in the directions perpendicular to the read-out 
direction. For two-dimensional imaging, the above process is repeated with 
different gradients applied in the second dimension for short intervals prior to 
acquisition, and the position is this time encoded in the phase of the signal 
rather than the frequency. The number of these ‘phase encoding’ steps is 
generally equal to the number of pixels in the phase-encode direction. The 
time required for each phase-encoding step is known as the repetition time 
(TR). 
For slice selection, a magnetic field gradient is applied perpendicular to 
the frequency- and phase-encoding direction when an RF excitation pulse is 
played out. By using a RF excitation pulse that only contains a narrow range 
of frequencies, only nuclei within a narrow slice are excited. Frequency-
encoding, phase encoding and slice selection are the processes necessary to 
obtain a two-dimensional image from a discrete slice of the sample. A feature 
particularly important for cardiac imaging is the ability to select even oblique 
views. This is achievable by modifying the frequency of the RF pulse, and by 
adaptations to the gradients. 
The term “pulse sequence” or “imaging sequence” describes the way in 
which the scanner plays out RF pulses and gradient fields and how it acquires 
and reconstructs the resultant data to form an image. Different orders of these 
pulses have defined names to describe them, such as FLASH (Fast Low 
Angle SHot), SSFP (Steady-State Free Precession) and TSE (Turbo Spin 
Echo). 
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As mentioned before, a challenge for CMR remains the acquisition of 
high spatial and temporal resolution images of a constantly moving structure 
within an acceptable scan time. Cardiac motion is compensated for by cardiac 
gating. An electrocardiogram (ECG) signal is co-registered throughout the MR 
examination and can be used prospectively to trigger the image acquisition to 
the R-wave of the ECG. Typically, 80-90% of the cardiac cycle is covered by 
this method, i.e. a short part of the end-diastolic phase is missing. In 
retrospective cardiac gating, the co-registered ECG is used to later assign 
data, continuously acquired throughout the cardiac cycle, to specific cardiac 
frames or phases (this term is not equivalent to the phase of a spin, but 
relates to a temporal stage of the cardiac cycle). To compensate for 
respiratory motion, two fundamentally different methods have been applied in 
CMR. The most commonly used method is the data acquisition within a single 
breath-hold. Alternatively, navigator techniques can be used obviating the 
need for breath-holding. A navigator, typically placed over the dome of the 
diaphragm, allows co-registration of the position of the diaphragm and 
generally only accepts acquired MR signals within a narrow diaphragm 
position window. The advantages of navigator based imaging is that it allows 
patients to breathe freely and to achieve high temporal and spatial resolution; 
however this is at the cost of substantially longer scan time. As the duration of 
a breath-hold is limited, a number of clever methods have been developed to 
achieve high quality images within the length of a breath-hold. As already 
discussed, the number of acquisitions per R-R interval (one heart beat to 
next) is determined by the MR scanner capabilities. However, one must 
choose the number of temporal cardiac phases or frames to image as well as 
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the number of excitations per frame (also known as the number of views per 
segment). For each cardiac phase, the scanner can only gather data to fill a 
fraction or segment of k-space (k-space is an array of numbers whose Fourier 
transformation is the MR image); hence the term segmented k-space filling. 
For each R-R interval, similar segments of k-space can be filled in many 
different cardiac phases. For example, if a resolution of 128 is desired in the 
phase-encoding direction, and the number of excitations per segment is 8 (i.e. 
8 lines of k-space are filled in a certain cardiac frame per R-R interval), thus 
requiring 16 heartbeats (8x16=128) to completely fill k-space. However, since 
many more RF excitations are performed per heartbeat, segments of k-space 
during other cardiac phases are also collected, as shown in Figure 1.1. The 
number of cardiac phases that can be acquired depends on the heart rate, 
number of lines of k-space per segment, and the TR. Shortening the breath-
hold time by increasing the number of lines acquired per cardiac phase to fill 
k-space comes at a cost. Increasing the number of lines acquired per 
segment or cardiac phase results in more blurring of the image and at the 
same time provides less time to collect data for other cardiac phases, i.e. 
reducing the temporal resolution. A clever method of increasing the number of 
temporal frames without changing the acquisition is called view sharing 
(Figure 1.2). With this technique frames are interpolated between the 
acquired frames, thereby almost doubling the temporal resolution without 
changing the spatial resolution. For example, if one is acquiring four 
excitations per segment for each frame, the last two views of one segment 
are combined with the first two views of the next segment to make another 
image frame. 
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Figure 1.1: Single slice, multiple-frame (or phase) gated segmented k-
space technique. Number of excitations per segment = 5. 
ECG=electrocardiogram. Adapted from Elster and Burdette (Elster and 
Burdette, 2001). 
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Figure 1.2: View sharing almost doubles the temporal resolution of cine 
images without changing the spatial resolution. Excitations from two adjacent 
segments are shared to make an additional cardiac frame or phase. Adapted 
from Elster and Burdette (Elster and Burdette, 2001). 
Chapter 1 19 D.Phil. thesis: S.E. Petersen 
 
 
If all the nuclei behaved identically, then the intensity at a pixel would 
depend solely on the concentration of that nucleus at that location in the body. 
However, several additional mechanisms make MRI a fundamentally more 
powerful technique. 
The longitudinal relaxation time (T1) is the time it takes for the signal to 
recover after an excitation pulse. Consequently, in pulse sequences with a 
short TR, tissue components with a long T1 will not recover fully and will be 
darkened in the image (this effect is known as saturation), whereas tissues 
with a short T1 will be brighter in the image. T1 contrast can also be 
manipulated by changing the size of the excitation pulse (this parameter is 
known as the flip angle), as the spins will require more time to recover from 
the application of a large flip angle than from a small one. Consequently, 
decreasing TR and increasing the flip angle will both increase the amount of 
T1-weighting and vice versa. 
The transverse relaxation time (T2) results from spins losing their 
phase coherence in the transverse plane and thus relates to the time that the 
signal is available for sampling after excitation. In T2-weighted images the 
signal is acquired a short period after the excitation of the nucleus, termed 
echo time (TE). Tissue with a short T2 will be darkened almost completely in 
the image, whereas tissue components with a long T2 will be brighter. 
Increasing TE will lead to images being more T2-weighted. 
Phase velocity methods allow quantification of either flow or myocardial 
velocities (Bryant et al., 1984). The field gradients are used to encode the 
position of the blood or myocardium in the phase of the signal and then 
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decode this position at a later time. Stationary signal is unaffected by this 
encoding and decoding, but moving structures undergo a change in the phase 
of their signal which provides quantitative information on flow and velocity. 
1.1.2 Cardiac magnetic resonance spectroscopy 
CMR imaging uses the 1H nucleus in water and fat molecules as its 
only source. In contrast, in cardiac MR spectroscopy (MRS) many additional 
nuclei which have a net nuclear spin, can be studied, as well summarized in 
recent reviews and book chapters (Neubauer, 2003; Neubauer and Clarke, 
2003). The most extensively studied nucleus in cardiac MRS is 31P, but 1H 
(protons from metabolites other than water and fat), 13C and 23Na can be 
used. MRS is the only available method for the non-invasive study of cardiac 
metabolism without external radioactive tracers (as used for example in 
positron emission tomography), but is limited by low spatial and temporal 
resolution. The nuclei studied with MRS have low MR sensitivity (e.g. for 31P, 
6.6% that of 1H) and are present in much lower concentrations than those of 
1H nuclei of water and fat (e.g. for 31P, 1 to 15x10-3 Molar vs. 110 Molar). 
Therefore, the resolution of MRS is several orders of magnitude lower than 
that of CMR imaging. 
There are hardware requirements that usually do not come with a 
standard CMR system for human cardiac 31P-MRS studies: The 
radiofrequency (RF) generator has to be able to produce frequencies other 
than for 1H (broadband capability), and a nucleus-specific (here 31P) RF 
cardiac surface coil is used for MR excitation and signal reception. 
Corresponding to the basic principles described for CMR imaging, a RF pulse 
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causes spin excitation and the resulting MR signal, the free induction decay 
(FID), is then recorded. The FID is subjected to Fourier transformation, which 
results in an MR spectrum. For practical patient comfort reasons, the 
acquisition time is limited to about 30-45 minutes. Thus, the resolution of MRS 
cannot be simply improved by lengthening the acquisition time. ECG gating is 
required, whilst respiration gating is currently not employed given the large 
voxel sizes and the already extended acquisition time. It is currently 
recommended to perform MRS studies prone rather than supine, as this 
reduces respiratory motion artefacts and brings the heart closer to the surface 
coil, improving sensitivity. The cardiac muscle lies behind the chest wall 
skeletal muscle, whose 31P-signal requires suppression by means of 
spectroscopic localisation techniques (Bottomley, 1994), such as 3-
dimensional (D)-CSI (chemical shift imaging), the technique used in our 
studies. Pohmann and von Kienlin (Pohmann and von Kienlin, 2001), have 
recently implemented acquisition-weighted 31P-chemical shift imaging, which 
reduces the signal contamination between adjacent voxels. For the first time, 
31P-spectra from the posterior wall could be obtained. Acquisition-weighting 
should thus be implemented for all cardiac MRS protocols, although the 
analysis of spectra most distant from the surface coil still remain a challenge 
and are highly dependent on the signal-to-noise ratio available in a given 
voxel. 
A typical 31P-MR spectrum from a healthy volunteer is shown in figure 
1.3. A human 31P-spectrum shows six resonances, corresponding to the three 
31P-atoms of adenosinetriphosphate (ATP) (labelled as α-, β- and γ-ATP), 
phosphocreatine (PCr), 2,3-Diphosphocglycerate (2,3-DPG, arising from 
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erythrocytes) and phosphodiesters (PDE, a signal due to membrane as well 
as serum phospholipids). Chemical shift causes different metabolites to 
resonate at specific frequencies, and this is quantified relative to the external 
magnetic field B0 (in ppm=parts per million). Different positions of the atoms 
under investigation within the molecule lead to subtle alterations in the local 
magnetic field strength, spreading the resonance frequencies of 31P-
metabolites over a range of ~30 ppm. From the fully relaxed state, the area 
under each 31P-resonance is proportional to the amount of each 31P-nucleus 
in the sample, and metabolite resonances are quantified by measuring peak 
areas. Relative metabolite levels are calculated, such as the PCr/ATP ratio. 
The PCr/ATP ratio is a powerful indicator of the energetic state of the heart.  
Healthy volunteer
PCr
ATP
γ
α
β
PDE
2,3-DPG
ppm
10         5          0         -5       -10      -15
 
Figure 1.3: 31P spectra from the basal anterior myocardium of a healthy 
volunteer, obtained from 31P acquisition weighted chemical shift imaging 
datasets. 
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In MRS, it is important to account for the effects of partial saturation 
when selecting pulse angles and TR: a full MR signal can only be obtained 
when the nucleus is excited from a fully relaxed spin state, i.e., when a time of 
at least 5 x T1 has passed since the previous excitation (for example, T1 of 
PCr at 1.5 Tesla ~4.4 s requiring TR of 22 s). Fully relaxed spectra can 
therefore only be obtained with long TR, leading to prohibitively long 
acquisition times. In practice, a shorter TR is used, leading to partially 
saturated spectra. Since the T1 of 31P-metabolites such as PCr and ATP 
differs (T1 of PCr is ~ twice as long as T1 of ATP), the degree of saturation 
also varies for different 31P-resonances. Thus, when quantifying partially 
saturated spectra, saturation factors need to be used for correction. These 
factors are determined for each metabolite by comparing fully relaxed and 
saturated spectra. In addition, to account for saturation, either adiabatic 
pulses (creating identical flip angles across the entire sample volume) or B1 
(B1 denotes the rotating magnetic field generated by an RF pulse) field 
characterisation (taking into account variations in flip angle) are required. 
Blood contributes signal to the ATP-, 2,3-DPG- and PDE-resonances of a 
cardiac 31P-spectrum. As human blood spectra show an ATP/2,3-DPG area 
ratio of ~0.11 and a PDE/2,3-DPG area ratio of ~0.19, for blood correction, 
the ATP resonance area of cardiac spectra is reduced by 11% of the 2,3-DPG 
resonance area, and the PDE resonance area is reduced by 19% of the 2,3-
DPG resonance area (Neubauer et al., 1992). 
1.2 Cardiac remodelling 
The consensus paper from an international forum on cardiac 
remodelling distinguishes physiological remodelling, a compensatory adaptive 
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change to long-term exercise, from pathological forms. Pathological forms of 
cardiac remodelling are defined as “genome expression, molecular, cellular 
and interstitial changes that are manifested clinically as changes in size, 
shape and function of the heart after cardiac injury” (Cohn et al., 2000). 
Traditionally, the term cardiac remodelling was used to describe 
compensatory cardiac changes in size, shape and function after a myocardial 
infarction as the primary cardiac injury. However, cardiac remodelling is now 
used in a much broader sense, including conditions with pressure-overload 
(aortic stenosis, hypertension), volume-overload (valvular regurgitation), 
inflammatory heart muscle disease (myocarditis) or idiopathic dilated 
cardiomyopathy. In this thesis, the focus is on primarily non-ischaemic (i.e. 
not coronary artery disease) cardiac remodelling, including athlete’s heart as 
the physiological form of remodelling and left ventricular (LV) hypertrophy 
secondary to hypertension and aortic stenosis, hypertrophic and dilated 
cardiomyopathy and left ventricular non-compaction as the pathological forms 
of cardiac remodelling. 
1.2.1 Physiological remodelling in athlete’s heart 
Athlete’s heart represents a physiological adaptation either to 
pressure- (strength-trained athletes, e.g. weight lifting) or volume-overload 
(endurance-trained athletes, e.g. cycling), leading to concentric or eccentric 
LV hypertrophy, respectively. Most sporting disciplines yield a combination of 
both mechanisms (Morganroth et al., 1975; Pelliccia et al., 1991; Maron et al., 
1995; Pelliccia et al., 1999; Pluim et al., 2000; Maron, 2003; Whyte et al., 
2004b). Cardiac dimensions are closely related to body size and composition 
(Henry et al., 1980; Gardin et al., 1987), an important factor to be taken into 
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account when interpreting echocardiographies or CMR scans of athletes. In 
the literature, female athletes have typically been underrepresented: Recent 
meta-analyses included male athletes in 59 studies and female athletes in 
only 13 studies (Pluim et al., 2000; Whyte et al., 2004a). Female athletes 
have larger LV cavity dimensions and maximal wall thickness compared with 
sedentary controls (Pelliccia et al., 1996). Nevertheless, and not surprisingly, 
women show smaller absolute LV cavity dimensions and wall thicknesses in 
comparison with male athletes (Pelliccia et al., 1991; Pelliccia et al., 1996). 
Furthermore, little data exist addressing the degree of right ventricular (RV) 
adaptive changes to exercise training, mainly due to the limited 
echocardiographic access to the right ventricle (Scharhag et al., 2002; 
D'Andrea et al., 2003a; D'Andrea et al., 2003b). Whether sex-specific 
differences in physiological LV and RV cardiac remodelling exist cannot be 
answered with confidence due to the lack of studies in athletes with age- and 
sex-matched sedentary controls. We performed such a study and the data are 
presented in Chapter 5. A genetic influence in the cardiac remodelling of 
athletes has been demonstrated for the renin-angiotensin system 
(Montgomery et al., 1997; Karjalainen et al., 1999). Recent findings have 
indicated that physiological hypertrophy may result from the activation of Akt 
through a phosphoinositide 3-kinase (PI3K) pathway (McMullen et al., 2003), 
a finding not observed in pathological forms of LV hypertrophy. In contrast to 
pathological forms of cardiac hypertrophy, upper limits of LV remodelling 
appear to exist for changes seen in athletes. Athletes with average training 
programmes almost never exceed the range of normal LV dimensions: An 
average of 10% increase for cavity size and 15% for wall thickness has been 
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reported compared with matched untrained controls (Maron et al., 1986). Elite 
athletes, however, can present with cardiac dimensions in a grey area or 
overlap area with hypertrophic and dilated cardiomyopathy. 2% of such highly 
trained athletes present with substantial wall thickening (≥ 13 mm), suggestive 
of hypertrophic cardiomyopathy (Pelliccia et al., 1991) and 15% show marked 
LV dilatation (end-diastolic diameter of LV cavity ≥ 60 mm), compatible with a 
diagnosis of dilated cardiomyopathy (Pelliccia et al., 1999). 
1.2.2 Pathological remodelling 
1.2.2.1 Hypertrophic cardiomyopathy 
Hypertrophic cardiomyopathy (HCM) is a disease entity characterised 
by the development of cardiac hypertrophy without obvious cause (Spirito et 
al., 1997). It is one of the most common single-gene disorders of the heart, 
affecting up to 1 in 500 of the population and is inherited in an autosomal 
dominant pattern (Redwood et al., 1999; Seidman and Seidman, 2001). Many 
patients are asymptomatic, though dyspnoea and chest pain are common 
clinical features (Spirito et al., 1997). Sudden cardiac death, however, is a 
well recognised feature of the disease, and HCM is the most common cause 
of sudden death in the younger population (Maron et al., 1996). Apart from a 
variable degree of cardiac hypertrophy, the typical pathological features of the 
disease are the development of myocyte and myofibrillar disarray and 
increased interstitial fibrosis (Figure 1.4). 
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Figure 1.4: 31-year old patient with HCM. A/B horizontal long axis and C/D 
short axis views. A and C are end-diastolic images for the analysis of 
geometry, myocardial mass, volumes and function using steady-state free 
precession cine-sequences. B and C are corresponding end-diastolic images 
obtained with the delayed enhancement technique, where signal-intense 
areas represent fibrotic tissue and the normal myocardium appears dark. 
Note the patchy signal-intense areas in the anteroseptal wall (black arrows). 
Overall, fibrotic tissue accounts for 69.5 g in this patient. This translates to 
19% of total left ventricular mass (365 g). 
The molecular genetic basis of HCM is now largely known as, in the 
majority of families, the disease results from mutations in genes encoding 
components of the cardiac contractile apparatus; thus, for the last decade 
HCM has been considered a “disease of the sarcomere” (Thierfelder et al., 
1994). To date, nine sarcomeric disease genes have been identified in which 
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mutations cause HCM, and this genetic heterogeneity contributes to the 
clinical heterogeneity of the disease. 
In most instances, HCM results from single nucleotide substitutions 
resulting in missense mutations, i.e. causing the substitution of a single amino 
acid in the protein generated. There is extensive evidence that these mutant 
proteins incorporate into the sarcomere, which presumably then malfunctions 
in some critical way (Redwood et al., 1999). The initial assumption was that a 
fundamental perturbation of contractility caused HCM. Early experimental 
evidence implicated depressed contractile function, suggesting that the 
cardiac hypertrophy was a compensatory response mediated by mechanical 
and neuroendocrine signalling. However, subsequent data suggested that 
different sarcomeric mutations have opposing influences, with many (probably 
the majority) resulting in hypercontractility; there is thus no consistent change 
in contractility on which to base models of disease pathogenesis. Instead, 
analysis of empirical data from biophysical studies of the different classes of 
mutant proteins lead to the suggestion that the unifying abnormality amongst 
HCM mutant proteins was reduced mechanical efficiency that would increase 
the energy cost of force production (Sweeney et al., 1998; Redwood et al., 
1999; Ashrafian et al., 2003). These theoretical predictions have since been 
supported by experimental measurements of the amount of ATP consumed 
per unit force generated by HCM mutant sarcomeres (Montgomery et al., 
2001). 
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1.2.2.2 Left ventricular non-compaction 
Left ventricular non-compaction (LVNC) is characterized by the 
presence of an extensive myocardial trabecular layer lining the cavity of the 
left ventricle, and potentially leads to cardiac failure, thromboembolism 
(Figure 1.5), and malignant arrhythmias (Chin et al., 1990; Ritter et al., 1997; 
Ichida et al., 1999; Oechslin et al., 2000; Stollberger et al., 2002). Within this 
trabecular layer, it is frequently possible to find thick and prominent coarse 
trabeculations separated by deep intertrabecular recesses (Feldt et al., 1969; 
Dusek et al., 1975; Chin et al., 1990; Michel et al., 1998; Angelini et al., 1999; 
Jenni et al., 1999; Oechslin et al., 2000; Jenni et al., 2001; Finsterer et al., 
2002; Oechslin and Jenni, 2002; Finsterer et al., 2003a; Stollberger and 
Finsterer, 2004; Weiford et al., 2004). Histological specimens show that the 
deep recesses are lined by endothelium, which extends close to the surface 
of the persisting compacted ventricular layer.
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Figure 1.5: A 46 year old previously fit and healthy male was admitted with 
a right femoral artery embolus, which was immediately removed by 
percutanous thrombectomy. Cardiovascular magnetic resonance imaging 
showed severely reduced left and right ventricular global function with marked 
biventricular dilatation. Both left and right ventricle showed a thick non-
compacted and a thin compacted layer with a diagnostic left ventricular 
systolic non-compaction-to-compaction ratio of 3.6 (A). Thrombus imaging 
early after Gadolinium-DTPA administration revealed two apical left 
ventricular thrombi within the non-compacted layer of myocardium (B). 
The condition can be associated with a wide variety of neuromuscular 
disorders (Chin et al., 1990; Stollberger et al., 1996; Ichida et al., 1999; 
Finsterer et al., 2001; Ichida et al., 2001; Stollberger et al., 2002) and other 
cardiac malformations (Ichida et al., 1999; Oechslin et al., 2000). Dusek and 
his colleagues provided one of the earliest substantial descriptions of the 
entity that represents what is now called LVNC (Dusek et al., 1975). The 
isolated form was first described in 1990 by Chin and colleagues (Chin et al., 
1990). As based on echocardiographic studies, the prevalence is estimated at 
0.05% in the general population (Ritter et al., 1997). In this regard, Jenni and 
co-workers (Jenni et al., 2001) suggested the echocardiographic finding of a 
ratio of greater than two between the non-compacted and compacted 
myocardium in systole to be diagnostic. Echocardiography, however, poses 
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inherent problems in assessing the left ventricular apex, known to be the most 
common non-compacted area (Moon et al., 2004). Furthermore, patients with 
the condition may be misdiagnosed as apical hypertrophic cardiomyopathy 
using echocardiography (Ichida et al., 1999). Similarly, involvement of the 
right ventricle remains controversial, first because of the more trabeculated 
nature of the right ventricle itself, and second, due to problems with 
echocardiographic access to the right ventricle behind the sternum. Previous 
echocardiography studies have reported right ventricular involvement in less 
than half the patients with LVNC (Ritter et al., 1997; Zambrano et al., 2002), 
but whether this reflects the true prevalence of concomitant right ventricular 
non-compaction remains to be determined. In Chapter 7 we present our data 
on diagnostic accuracy for LVNC using cardiovascular magnetic resonance 
imaging. 
LVNC is not currently classified as a distinct form of cardiomyopathy by 
the Word Health Organisation (Richardson et al., 1996), and its underlying 
pathophysiological mechanisms remain controversial and ultimately unknown 
(Finsterer et al., 2003b). LVNC may be a developmental abnormality, 
reflecting either impaired or arrested compaction of the developing 
myocardium (Dusek et al., 1975; Chin et al., 1990; Steiner et al., 1996; 
Angelini et al., 1999; Jenni et al., 1999; Victor et al., 1999; Jenni et al., 2001; 
Stollberger and Finsterer, 2004; Weiford et al., 2004). Stollberger, Finsterer 
and their colleagues, suggest suggest considering other mechanisms, 
including dissection of the myocardium, frustrated attempt to myocardial 
hypertrophy, myocardial tearing caused by dilatation, a metabolic defect, or 
compensatory hypervascularisation (Stollberger and Finsterer, 2004). 
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Amongst Japanese children with LVNC (Ino et al., 1993), more patients 
are asymptomatic on presentation and have fewer systemic embolic events 
and episodes of ventricular tachycardia when compared to the observations 
of Chin et al (Chin et al., 1990). Ichida and colleagues (Ichida et al., 1999) 
suggest that this difference may be accounted for by the fact that LVNC in 
their patients was detected incidentally during a screening study of an entire 
population of Japanese children. Whether the extent or degree of 
hypertrabeculation has a role in determining the timing of presentation, and 
severity of clinical course, is also uncertain, although this has been suggested 
(Chin et al., 1990; Wald et al., 2004). Because of the known genetic 
heterogeneity (Digilio et al., 1999), it is yet to be determined if a specific 
genetic marker may contribute to either the severity or timing of presentation. 
One attractive mechanism for the progression into cardiac dysfunction in 
LVNC may lie in altered cardiac energetics, similar to the situation in 
hypertrophic (Jung et al., 1998; Crilley et al., 2003) or dilated cardiomyopathy 
(Neubauer et al., 1992; Beer et al., 2002). Confirmation of such a mechanism 
would have two clinical implications: First, this would suggest treatment 
strategies aimed to improve myocardial energetics. Second, PCr/ATP ratios 
offer the hope of serving as a discriminator of a benign vs. malignant course 
in LVNC cases, as was shown in dilated cardiomyopathy (Neubauer et al., 
1997a). Thus, we aimed to investigate cardiac energetics in a group of LVNC 
patients who have not or not yet developed cardiac dysfunction, to study 
whether cardiac energetics derangement can be demonstrated early in the 
disease process suggesting altered energetics as a factor contributing to the 
development of heart failure in LVNC. We present our findings of deranged 
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cardiac metabolism in LVNC patients with preserved LV ejection fraction in 
Chapter 8. 
Ichida and colleagues (Ichida et al., 1999) reported several years ago 
that, in patients with isolated LVNC, familial recurrence is high, being found in 
approximately two-fifths of patients, a conclusion shared by others (Chin et 
al., 1990; Oechslin et al., 2000; Jenni et al., 2001; Neudorf et al., 2001; 
Stollberger and Finsterer, 2004). Mutations in the gene G4.5, which encodes 
taffazin, and maps to chromosome Xq28, are responsible for this myocardial 
disorder in some patients, being allelic with Barth Syndrome (Bione et al., 
1996; Bleyl et al., 1997a; Bleyl et al., 1997b; Matsuda et al., 1999; Ichida et 
al., 2001; Chen et al., 2002). G4.5 was initially identified as the gene 
responsible for Barth syndrome, an X-linked mitochondrial disease affecting 
cardiac and skeletal muscle (Neustein et al., 1979; Barth et al., 1983). These 
mutations produce a wide phenotypic spectrum of cardiomyopathies, 
including dilated cardiomyopathy, X-linked infantile cardiomyopathy, and X-
linked endocardial fibroelastosis (Ichida et al., 2001). Ichida and colleagues 
(Ichida et al., 2001) found a mutation in α-dystrophin in some of their patients. 
A novel mutation of intron 8 of G4.5 in one family with severe X-linked LVNC, 
but without the other usual findings of Barth Syndrome has been reported 
(Chen et al., 2002). Deletion of chromosome 5q has been identified in a child 
with previously repaired congenital heart disease, facial dysmorphism, and 
LVNC (Pauli et al., 1999). Vatta and co-workers have shown that a mutation 
in Cypher-Zasp, a gene encoding a protein that is a component of the Z-line 
in both skeletal and cardiac muscle, may be causal (Vatta et al., 2003). 
Interestingly, mice lacking FKBP12 have normal skeletal muscle, but have a 
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severe dilated cardiomyopathy and a condition suggestive of LVNC (Shou et 
al., 1998).  
In adults identified with the sporadic form of isolated LVNC, it is an 
autosomal dominant disorder rarely caused by mutations in G4.5, and hence 
is genetically distinct from the X-linked cases seen in infancy (Kenton et al., 
2004; Sasse-Klaassen et al., 2004). Sasse-Klaassen and colleagues mapped 
the responsible gene to chromosome 11p15 in a family with an autosomal 
dominant form of LVNC (Sasse-Klaassen et al., 2003). Interestingly, this 
study describes family members with a partial expression of the phenotype for 
LVNC. LVNC may also be associated with mutations in the lamin A/C gene 
(Hermida-Prieto et al., 2004). 
1.2.2.3 Hypertensive heart disease 
Hypertension affects approximately 50 million individuals in the United 
States and approximately 1 billion individuals worldwide (Chobanian et al., 
2003). In a cross-sectional population-based study of 734 essential 
hypertensive patients, the prevalence of LV hypertrophy ranged from 
approximately 50% to 70% depending on the LV hypertrophy definition 
(Conrady et al., 2004). The traditional concept of heart failure development 
via hypertension, concentric LV hypertrophy, myocardial fibrosis and 
contractile dysfunction, albeit attractive, may be too simplistic and is not 
supported by a large body of evidence. As hypertension is an independent 
risk factor for coronary artery disease, at least a substantial proportion of 
hypertensive hearts with systolic impairment will be caused by a mismatch of 
increased oxygen demand (hypertrophy) and reduced oxygen supply 
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(coronary artery disease). Hypertensive heart disease patients were studied 
in this thesis as a model of pressure-overload LV hypertrophy. 
1.2.2.4 Aortic stenosis 
A degenerative process is the most common cause of aortic stenosis in 
adults. The aortic valve area must be reduced to one fourth its normal size 
before significant changes in haemodynamics occur. In adults with aortic 
stenosis, the obstruction develops gradually. During this time, the LV adapts 
to pressure overload through a concentric hypertrophic process with increase 
in LV mass and wall thickness, while chamber size and ejection fraction are 
preserved (Bonow et al., 1998). The hypertrophied heart may have reduced 
coronary flow and coronary flow reserve, even in the absence of epicardial 
coronary artery disease (Bache et al., 1981; Marcus et al., 1982). LV 
hypertrophy secondary to aortic stenosis was investigated in this thesis as 
another model of pressure-overload hypertrophy. 
1.3 Cardiac energetics in physiological and pathological left 
ventricular hypertrophy 
31P-Magnetic resonance spectroscopy studies support the notion that 
cardiac remodelling due to long-term exercise training behaves differently 
from pathological forms of LV hypertrophy. Myocardial PCr/ATP ratios remain 
normal at rest and during stress in athletes (Pluim et al., 1996; Pluim et al., 
1998). Experimental work in rats had predicted this finding (Spencer et al., 
1997). 
Increasing evidence based on data from animal models and patients 
strongly supports the energy depletion hypothesis as a unifying mechanism 
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leading to hypertrophy in HCM. Impaired energetics (decreased PCr/ATP-
ratios in cardiac 31P-MRS) have been documented in genetically modified 
animal models (Spindler et al., 1998; Javadpour et al., 2003) of HCM as well 
as in asymptomatic patients with clinical features of HCM (Jung et al., 1998) 
and in genotyped, phenotypically affected and phenotypically unaffected 
(gene carrier), HCM patients (Crilley et al., 2003). 
Only three 31P-MRS studies have examined patients with LV 
hypertrophy due to chronic hypertension. Lamb et al (Lamb et al., 1999) 
demonstrated reduced PCr/ATP ratios in patients with hypertension both at 
rest and during dobutamine stress testing. Furthermore, PCr/ATP ratio 
showed a negative correlation with diastolic function indices. In contrast, two 
other studies showed no significant changes in cardiac energetics in 
hypertension (Okada et al., 1998; Beer et al., 2002). A possible explanation 
for these discrepant findings may lie in different severity of LV hypertrophy 
and different duration of hypertension in the studied populations. 
Experimental work clearly suggests that cardiac energetics are impaired in 
long-standing hypertension (Perings et al., 2000). 
Experimental studies suggest alterations in myocardial energy 
metabolism for advanced LV hypertrophy (Wexler et al., 1988; Zhang et al., 
1993). Conway et al demonstrated reductions of PCr/ATP ratios by 36% in 
patients with LV hypertrophy due to aortic stenosis or incompetence only if 
clinical signs of heart failure were present, while PCr/ATP ratios remained 
unchanged for asymptomatic cases (Conway et al., 1991). These findings 
were confirmed by another study documenting reduced PCr/ATP ratios in 
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patients with aortic valve disease in NYHA (New York Heart Association) 
stage III and IV, but not in stage I and II (Neubauer et al., 1997b). 
Interestingly, this study showed that for patients with the same degree of LV 
hypertrophy cardiac energetics were more severely altered in patients with 
pressure-overload hypertrophy, i.e. due to aortic stenosis, when compared to 
those with overload-hypertrophy, i.e. due to aortic valve incompetence. A 
further interesting aspect of this study was the finding of an inverse correlation 
between PCr/ATP ratios and LV end-diastolic pressures and wall stress. In a 
study performing absolute quantification of PCr and ATP in patients with 
aortic stenosis, ATP concentration remained unchanged with a 28% reduction 
in PCr concentration (Beer et al., 2002). A follow-up study determined cardiac 
PCr/ATP ratios in patients undergoing aortic valve surgery due to severe 
aortic stenosis before and 40 weeks after surgery, when LV hypertrophy had 
regressed. PCr/ATP ratios, which were decreased by 12% before surgery 
compared to healthy controls, returned to normal after successful surgery 
(Beyerbacht et al., 2001). 
1.4 Differentiation of physiological and pathological left ventricular 
hypertrophy 
The athlete’s heart was first described and observed in cross-country 
skiers by carefully performed percussion of the chest at the end of the 19th 
century (Rost and Hollmann, 1983). For decades, determination of outer 
cardiac contours by physical examination and chest X-rays were the only 
available diagnostic tools for assessment of athlete’s heart. The introduction 
of echocardiography has enabled in vivo morphological assessment of 
athlete’s hearts, and subsequently diagnostic markers to distinguish 
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physiological from hypertrophic cardiomyopathy have been proposed (Maron 
et al., 1995). Hypertrophic cardiomyopathy is more likely than physiological 
hypertrophy if the hypertrophy is asymmetric and presents with an unusual 
pattern of abrupt changes in wall thickness between adjacent segments. A 
small LV cavity (≤ 45 mm) and abnormal LV filling pattern both suggest 
hypertrophic cardiomyopathy rather than athlete’s heart, in which the LV 
cavity would be expected to be enlarged (≥ 55 mm) with normal LV filling 
patterns (Maron et al., 1995). However, a grey area exists, so that in clinical 
practice, the distinction of pathological and physiological LV hypertrophy 
remains a frequent clinical dilemma. Various pathological forms of LV 
hypertrophy, such as due to hypertrophic cardiomyopathy (HCM), 
hypertensive heart disease or aortic stenosis, and physiological forms of LV 
hypertrophy, such as in athlete’s hearts, can present with overlapping cardiac 
hypertrophy phenotypes as determined by 2D-echocardiography or ECG. In 
clinical practice, the distinction between physiological hypertrophy occurring in 
athletes and pathological hypertrophy is critical because HCM accounts for 
about one-third of exercise-related sudden deaths in young competitive 
athletes (Maron et al., 1980; Maron et al., 1986; Burke et al., 1991; Corrado et 
al., 1998). Furthermore, in athletes with hypertension, the relative 
contributions of increased blood pressure and physical training to the degree 
of LV hypertrophy detected need to be clarified, and this has implications as 
to the recommendation of treatment with antihypertensive agents in this 
situation. 
In current clinical practice, one strategy of distinguishing athlete’s heart 
from pathological LV hypertrophy is to document the deconditioning effect 
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after training cessation for several months (Martin et al., 1986; Maron et al., 
1993; Pelliccia et al., 2002). However, this is often not acceptable to athletes. 
Metabolic exercise testing has been shown to facilitate the differentiation 
between athlete’s hearts and HCM (Sharma et al., 2000). We studied a novel 
approach to distinguish athlete’s heart from various forms of pathological LV 
hypertrophy by means of three-dimensional CMR-derived LV volume and 
geometric indices, obviating the need for ‘de-training’ to make this distinction. 
These data are presented in Chapter 6. 
1.5 Study aims and hypotheses 
In chapter 3, we aimed to establish a large database of reference 
values for left and right ventricles of healthy volunteers using steady-state free 
precession techniques (SSFP), the preferred technique of choice for 
assessment of volume data in current clinical practice. 
In chapter 4, we aimed to demonstrate that tissue phase mapping, an 
MR technique to assess 3D myocardial velocities, would allow quantitative 
measurement of motion parameters which are reproducible and independent 
of analysers. Further, given the high resolution of tissue phase mapping, we 
hypothesized that this method would show differences between endo- and 
epicardium for radial, circumferential and longitudinal velocity parameters in 
healthy volunteers. Thus, the purpose of our study was to prospectively 
establish a database of normal, three-dimensional, systolic and diastolic, 
endo- and epicardial velocities of all myocardial segments in healthy 
volunteers using cine phase contrast velocity magnetic resonance imaging 
(tissue phase mapping or TPM). 
Chapter 1 40 D.Phil. thesis: S.E. Petersen 
 
 
In chapter 5, we aimed to study male and female young adult elite 
athletes with age- and sex-matched sedentary controls to assess sex-specific 
differences for LV and RV dilatation and hypertrophy as well as for LV 
contraction and relaxation. We hypothesized that structural and functional 
adaptive changes to exercise training would be sex-specific. 
In chapter 6, we employed CMR imaging to test whether CMR-derived 
LV volume parameters and geometric indices accurately predict the 
underlying aetiology of LV hypertrophy. This hypothesis was tested in groups 
of patients with HCM, hypertension and aortic stenosis, and in athletes. 
It is necessary to establish specific CMR criteria for the diagnosis of 
pathological non-compaction. To this end, we examined healthy volunteers as 
well as patients with potential differential diagnoses for LVNC. Findings from 
this group were compared with unequivocal LVNC cases in whom the 
diagnosis was supported by other clinical features. Data on diagnostic 
accuracy for LVNC are presented in chapter 7. 
LVNC is characterised by the presence of an extensive non-compacted layer 
of myocardium, which can lead to chronic cardiac failure. The non-compacted 
myocardium likely represents an embryological arrest of compaction, i.e., a 
mechanism distinct from other forms of cardiomyopathy with known alteration 
of cardiac energetics, such as dilated or hypertrophic cardiomyopathy. We 
hypothesized that patients with LVNC and maintained ejection fraction show 
reduced cardiac high-energy phosphate metabolism, suggesting altered 
energetics as a factor contributing to the development of heart failure in 
LVNC. Our findings are presented in chapter 8. 
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CHAPTER 2: Methods 
All individuals underwent a clinical study with two subsequent CMR 
scans performed on a 1.5 Tesla MR system (Sonata Maestro Class, Siemens 
Medical Solutions, Erlangen, Germany) ) equipped with a high performance 
gradient system (40mT/m peak strength, 200T/m/s maximum slew rate), and 
multi-nuclear capabilities enabling 31P MRS of the heart. 
2.1 Cardiac magnetic resonance imaging protocol 
Multi-modality CMR imaging, was designed to measure cardiac 
morphology, function and mass. After piloting, steady-state free precession 
cine images (SSFP, TE/TR 1.5/3.0 ms, flip angle 60°, in-plane resolution 1.5 x 
1.5 mm, slice thickness 7 mm, 3 mm inter-slice gap, temporal resolution 45 
ms,15 lines of k-space per heartbeat, 14-17 heartbeats per breath-hold, 
prospective ECG-gating) were acquired in long-axis views, i.e. horizontal and 
vertical long axis, and the LV outflow tract views. A short axis stack was 
obtained, parallel to the atrioventricular groove, covering the entire left 
ventricle. 
Phase contrast images (tissue phase mapping, TPM) were acquired 
with a prospectively triggered black blood k-space segmented gradient echo 
sequence (TE/TR=4.5/6.2 ms, flip angle=15°) with first-order flow 
compensation in all dimensions to minimize artefacts from flow or motion 
described in detail elsewhere (Hennig et al., 1998b; Markl and Hennig, 2001). 
The pixel size was 2.7 x 1.3 mm (field of view 255 x 340 mm, 96 x 256 matrix 
interpolated to 192 x 256) with a slice thickness of 8 mm. Velocity encoding 
was performed by adding a bipolar gradient in read, phase and slice direction 
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after each RF pulse to the otherwise identical sequence (velocity encoding 
(venc) in-plane=20 cm/s, venc through-plane=30 cm/s). The temporal 
resolution was 37 ms to 87 ms in a single breath-hold (baseline, x-, y- and z-
velocity components) over 17 to 29 heartbeats (adjustable to breath-holding 
capability). The quoted temporal resolution was achieved using view sharing 
techniques for which the resulting velocity errors have been shown to be 
small in structures the size of the myocardium (Markl and Hennig, 2001). The 
temporal resolution used for our study population (mean ± standard deviation 
(SD) of 62 ± 12 ms) showed very low correlation coefficients for mid-
ventricular radial peak systolic (r= 0.003) and diastolic (r=0.19) velocities 
suggesting that the temporal resolution applied would not significantly 
confound the acquired velocity parameters. Three short axis slices at basal 
(between the LV outflow tract and the papillary muscles), mid-ventricular and 
apical levels were acquired according to recommended guidelines by the 
American Heart Association (AHA) and the American College of Cardiology 
(ACC) to assess myocardial segments (Figure 2.1) (Cerqueira et al., 2002). 
The typical distance between the basal and the apical short axis slice was 4 
to 6 cm and positioning of the slices, expressed as percentage of the distance 
of the atrioventricular groove to the apex in the horizontal long axis, showed 
low variability. 
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Figure 2.1: Standardized myocardial 17 segment model (segment number 
given in brackets) and nomenclature for tomographic imaging of the heart: 
Adapted from a statement for healthcare professionals from the Cardiac 
Imaging Committee of the Council on Clinical Cardiology of the American 
Heart (Cerqueira et al., 2002). 
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2.2 Cardiac 31Phosphorus magnetic resonance spectroscopy protocol 
In order to detect possible changes in cardiac high-energy phosphate 
metabolism, cardiac 31P-MRS was performed at rest. All data were acquired 
with a commercially available heart/liver 31P/1H surface coil (Siemens Medical 
Systems, Erlangen, Germany). This coil contains a large single loop for 
excitation at both phosphorous (31P) and proton (1H) frequencies and for 
detection of 1H signals. It also contains a quadrature coil for detection of 31P 
signals, which comprises a figure-of-eight shaped loop and a circular coil. 
The 31P B1 fields of these coils (transmit and receive) were calculated 
according to the Biot-Savart law and verified by experiment. To enable 
determination of the coil position for field map orientation purposes, capsules 
of cod liver oil were placed within the four corners of the coil casing. By 
imaging these capsules at the beginning of each experiment, it was possible 
to map the coil profiles onto the individual volunteer position. 
All volunteers were positioned in a head first prone position, so that 
their heart was placed as close to the centre of the coil as possible. Correct 
positioning was confirmed with the use of a stack of limited field of view 
proton scout images. Following positioning and measurement of the cod liver 
oil markers, a series of unlocalised 31P inversion recovery FID acquisitions 
were acquired at different inversion times to measure the actual flip angle of a 
reference vial of phenylphosphonic acid (PPA) positioned inside the coil 
casing. Knowledge of this flip angle allows for calculation, via the calculated 
excitation B1 field map, of the localised flip angle at all points in the 
subsequently acquired spectra. 
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After piloting, a series of 32 double oblique SSFP images, oriented 
along the short axis of the heart were acquired. Image dimensions were 300 x 
225 mm (Matrix size 128 x 96), with a slice thickness of 8 mm. The images 
were cardiac gated, with acquisition occurring during the early part of diastole. 
A 31P 3D acquisition weighted CSI spectral data set was then acquired with 
the same position as the anatomical images but dimensions of 320 x 200 x 
240 mm, a Matrix size of 12 x 8 x 8 (zero-filled to 16 x 16 x 8). Hence, the 
spatial resolution was 26.7 x 25 x 30 mm3 (20 ml) interpolated to 20 x 12.5 x 
30 mm3 (7.5 ml). 
2.3 Analysis of cardiac magnetic resonance images 
CMR cine image analysis was performed with Argus software (Version 
2002B, Siemens Medical Solutions, Erlangen, Germany). Manual tracing of 
the endocardial and epicardial borders of successive short-axis slices at end-
diastole and end-systole (image with the smallest left and right ventricular 
cavity) was performed. Both epicardial and endocardial borders were traced 
on the end-diastolic frame, with only an endocardial border on end-systolic 
frame. The contour tracing was monitored by reviewing the movie with 
contours attached. 
The basal slice was selected for the left ventricle when at least fifty 
percent of the blood volume was surrounded by myocardium in both end-
diastole and end-systole. The apical slice was defined as the last slice 
showing intracavity blood pool. 
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For the right ventricle, volumes below the pulmonary valve were 
included. From the inflow tract, RV volumes were excluded if the surrounding 
muscle was thin and not trabeculated, suggestive of right atrium (Figure 2.2). 
 
Figure 2.2: End-diastolic short-axis images from base to apex in a healthy 
volunteer with endocardial and epicardial contours drawn for both the left and 
right ventricles. The basal slice was selected for the left ventricle when at 
least fifty percent of the blood volume was surrounded by myocardium in both 
end-diastole and end-systole. The apical slice was defined as the last slice 
showing intracavity blood pool. For the right ventricle, volumes below the 
pulmonary valve were included. From the inflow tract, RV volumes were 
excluded if the surrounding muscle was thin and not trabeculated, suggestive 
of right atrium. Papillary muscles were included in the LV mass. 
Papillary muscles were included in the mass and excluded from the 
volume calculations. The interventricular septum was included as part of the 
left ventricle. From these data, the mass, ejection fraction, end-systolic and 
end-diastolic volumes could be calculated. Myocardial mass was determined 
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by multiplication of the tissue volume by 1.05g/cm3 (specific density of 
myocardium). Functional parameters, normalised to body surface area were 
also calculated. 
TPM data analysis was performed on a personal computer using 
customized software programmed in Matlab Version 6.5 (The Mathworks Inc., 
Natick, MA) (Markl et al., 2002). After manual endo- and epicardial contour 
segmentation and a correction for translational motion components of the LV 
in the image plane (Hennig et al., 1998b), radial and circumferential velocities 
were calculated from in-plane velocities for each pixel based on an internal 
polar coordinate system positioned at the centre of mass of the LV. The 
longitudinal velocities were already encoded in the acquisition and were used 
without correction. The average velocity was computed for pixels within the 
epicardial (inner half of wall thickness), endocardial (outer half of wall 
thickness) and transmural regions for each of the 16 segments of the 17 
segment model according to the AHA/ACC recommendations (Cerqueira et 
al., 2002). The temporal axis of the three-dimensional systolic velocity 
information obtained was then normalized to the end-systolic time as defined 
by the smallest LV cavity on mid-ventricular cine images to avoid temporal 
jitter. Diastolic velocity information was similarly normalized to the duration of 
diastole (RR interval minus duration of systole). For each of the radial and 
longitudinal velocities, two systolic and two diastolic parameters were 
computed: systolic peak velocity, systolic time to peak velocity, diastolic peak 
velocity and diastolic time to peak velocity. These parameters were computed 
for endocardial, epicardial and transmural velocities in 16 segments 
(Cerqueira et al., 2002) and for averaged global basal, mid-ventricular and 
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apical velocities. In addition, the relative speed of motion between the basal 
and apical slice was plotted over the cardiac cycle as the difference between 
the circumferential (torsion-rate [rad.s-1.cm-1] defined as the rate of change of 
angular velocity along the heart) and longitudinal (longitudinal strain-rate [s-1]) 
velocities of the global basal and apical slices normalized to mid-ventricular 
short axis diameter and to ventricular length. Peak systolic torsion-rate, peak 
diastolic torsion-rate, systolic time to peak torsion-rate, diastolic time to peak 
torsion-rate and peak systolic longitudinal strain-rate, peak diastolic 
longitudinal strain-rate, systolic time to peak systolic longitudinal strain-rate 
and diastolic time to peak longitudinal strain-rate were then derived from 
those graphs. 
2.4 Analysis of cardiac 31Phosphorus magnetic resonance 
spectroscopy 
Cardiac high-energy phosphate metabolites (blood and T1 corrected 
PCr/ATP ratio, an index of the energetic state of the heart) were measured at 
rest using 31P-MR spectroscopy in the basal anterior myocardium. The 
processing was carried out using home-written software in Matlab 
(MathsWorks Inc, Natick, MA). The proton images and the 31P spectra were 
initially loaded and reregistered to one another, and to the previously 
calculated B1-field maps, using the images of the cod liver oil tablets. The flip 
angle at the PPA reference was then measured by fitting the inversion 
recovery data, after correcting for the off resonance position of the PPA, for 
the local flip angle and the T1 of the reference.  
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The spectra produced were quantified using the AMARES, time-
domain fitting algorithm within jMRUI 
(www.mrui.uab.es/mrui/mruiHomePage.html). This takes into account the j-
couplings and amplitude ratios of the different peaks as prior knowledge. The 
fitted amplitudes were then individually corrected for blood contamination and 
saturation effects using T1 and contamination values from the literature. 
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CHAPTER 3: Normal human left and right ventricular and left 
atrial dimensions using steady state free precession magnetic 
resonance imaging 
3.1 Introduction 
Cardiovascular magnetic resonance imaging (CMR) has become the 
gold standard method for the characterisation of cardiac anatomy, function 
and mass (Pennell, 2003). It is an accurate and reliable technique for the 
serial monitoring of patients, particularly in response to therapeutic 
intervention (Grothues et al., 2002). 
CMR is a well-tolerated, non-invasive technique without exposure to 
radiation with no known side-effects and is becoming increasingly available to 
the clinician. Establishment of a normal healthy reference database is 
essential for measurements to be useful and relevant in clinical practice. 
There are a number of different vendors and acquisition techniques, which 
may reflect some of the discrepancies in normal values for left and right 
ventricular parameters published in the literature (Lorenz et al., 1999; 
Sandstede et al., 2000; Alfakih et al., 2003). Furthermore, information 
regarding the left atrial size, volume and function is clinically important in the 
management of patients, particularly those with atrial fibrillation. Assessment 
of left atrial volumes using CMR has not yet become routine because it is not 
straightforward and the standard short-axis method of measuring left atrial 
volume and ejection fraction is very time-consuming. Echocardiography is 
currently the gold standard for assessing left atrial volumes but relies on a 
number of geometric assumptions. 
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It has been demonstrated that, when compared to the short-axis 
method in CMR, the biplane area-length method for ellipsoid bodies is a more 
rapid alternative in both healthy volunteers and patients which is both 
accurate and reproducible (Dulce et al., 1993; Sievers et al., 2004). 
We aimed to establish a large database of reference values for left and 
right ventricles of healthy volunteers using steady-state free precession 
techniques (SSFP), the preferred technique of choice for assessment of 
volume data in current clinical practice. Previously only one large series of 
SSFP values has been reported, using one specific vendor, which did not 
examine right ventricular mass in combination with left and right ventricular 
volumes in a single clinical examination (Alfakih et al., 2003). In addition, we 
aimed to study left atrial end-systolic and end-diastolic volumes, stroke 
volume and ejection fraction. 
3.2 Methods 
Study population 
108 healthy volunteers (63 male; mean age 38 ± 12 years, range 21-68 
years) were recruited with no history of cardiac disease, hypertension or 
cardiac risk factors and a normal baseline ECG. Volunteers with 
contraindications to CMR were not enrolled. The study was carried out 
according to the principles of the Declaration of Helsinki and was approved by 
our institutional ethics committee. Each subject gave informed written 
consent. Baseline characteristics of the healthy volunteers are shown in 
Table 3.1. 
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Table 3.1: Characteristics of healthy volunteers 
 Mean ± SD (n = 108) 
Age (years) 38 ± 12 
Gender 63 male/45 female
Height (cm) 174 ± 9 
Weight (kg) 73.4 ± 12.3 
Body Surface Area (m2) 1.88 ± 0.18 
Heart Rate (bpm) 65 ± 10 
Systolic Blood Pressure (mmHg) 123 ± 17 
Diastolic Blood Pressure (mmHg) 81 ± 16 
 
Cardiovascular magnetic resonance imaging protocol and image analysis 
The details of the CMR acquisition protocol and of the analysis of the 
LV and RV volume studies are described in detail in chapter 2.  
In addition to the LV and RV volume analysis, the left atrial (LA) 
volumes, ejection fraction and stroke volume were measured using the 
biplane area-length method in the horizontal and vertical long axes (Figure 
3.1). The left atrial appendage was included in the atrial volume, but the 
pulmonary veins were excluded. Left atrial stroke volume and ejection 
fraction:  
Stroke Volume (SV) = End-Diastolic Volume (EDV) – End- Systolic 
Volume (ESV) and Ejection Fraction (EF) = Stroke Volume (SV) /End- 
Diastolic Volume (EDV) x 100%. 
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Figure 3.1: Horizontal long axis (HLA) in end-diastole (A) and end-systole 
(B), vertical long axis (VLA) in end-diastole (C) and end-systole (D) illustrating 
contouring for the biplane are-length method for left atrial volumes and 
ejection fraction. The left atrial appendage was included in the atrial volume 
but the pulmonary veins were excluded. 
Reproducibility 
To assess inter-study reproducibility, 12 subsequent subjects 
underwent a second identical scan, separated by at least one week from the 
first study. 
Inter-observer variability was assessed by a second investigator 
analysing 12 of the data sets. One observer analysed the first 12 volunteer 
images twice, leaving a 6 week gap and blinded to the previous results, 
providing intra-observer variability. 
 
Chapter 3 54 D.Phil. thesis: S.E. Petersen 
 
Statistical Analysis 
All data are presented as mean ± standard deviation (SD) unless 
stated otherwise. 
For inter-study reproducibility, inter- and intra-observer variability was 
assessed using the method of Bland and Altman (Bland and Altman, 1986). 
The coefficient of variability was calculated as the SD of the differences 
between the two sets of measurements divided by the mean value of the 
parameter under consideration. All computations were performed with SPSS 
11.5 (SPSS Inc., Chicago, United States).  
3.3 Results 
Cardiovascular magnetic resonance scanning was well tolerated by all 
participants. All datasets were of sufficient quality to be included in the study. 
The values for left and right ventricular function and mass are shown in Table 
3.2. 
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Table 3.2: LV and RV measurements in 108 healthy volunteers 
 Mean ± SD(n = 108) 
Male 
(n = 63) 
Female 
(n = 45) P value 
LV ejection fraction (%) 69 ± 6 69 ± 6 (57-81) 
69± 6 
(57-81) 0.80 
LV mass (g) 112 ± 27 123 ± 21 (81-165) 
96 ± 27 
(42-150) <0.001 
LV mass index (g/m2) 59.2 ± 11 62.5 ± 9.0 (45-81) 
54.6 ± 12 
(31-79) <0.001 
LV end-diastolic volume 
(ml) 150 ± 31 
160 ± 29 
(102-218) 
135 ± 26 
(83-187) <0.001 
LV end-diastolic volume 
index (ml/m2) 80 ± 13 
82 ± 13 
(56-108) 
78 ± 12 
(54-102) 0.16 
LV end-systolic volume 
(ml) 47 ± 15 
50 ± 16 
(18-82) 
42 ± 12 
(18-66) 0.007 
LV end-systolic volume 
index (ml/m2) 25 ± 7 
25 ± 8 
(9-41) 
24 ± 6 
(12-36) 0.53 
LV stroke volume (ml) 104 ± 21 112 ± 19 (74-150) 
91 ± 17 
(57-125) <0.001 
LV stroke volume index 
(ml/m2) 55 ± 8 
56 ± 8 
(40-72) 
54 ± 9 
(36-72) 0.12 
RV ejection fraction (%) 61 ± 6 59 ± 6 (47-71) 
63 ± 5 
(53-73) 0.002 
RV mass (g) 38 ± 8 41± 8 (25-57) 
35± 7 
(21-49) <0.001 
RV mass index (g/m2) 20.3 ± 3.6 20.6 ± 3.7 (13-28) 
20.0 ± 3.5 
(13-27) 0.371 
RV end-diastolic volume 
(ml) 173 ± 39 
190 ± 33 
(124-256) 
148 ± 35 
(78-218) <0.001 
RV end-diastolic volume 
index (ml/m2) 91 ± 16 
96 ± 15 
(66-126) 
84 ± 17 
(50-118) <0.001 
RV end-systolic volume 
(ml) 69 ± 22 
78 ± 20 
(38-118) 
56 ± 18 
(20-92) <0.001 
RV end-systolic volume 
index (ml/m2) 36 ± 10 
39 ± 10 
(19-59) 
32 ± 10 
(12-52) <0.001 
RV stroke volume (ml) 104 ± 21 113 ± 19 (75-151) 
90 ± 19 
(52-128) <0.001 
RV stroke volume index 
(ml/m2) 55 ± 9 
57 ± 8 
(41-73) 
53 ± 9 
(35-71) 0.02 
Values are given as mean ± SD; reference ranges in brackets, calculated as ± 2SD of the 
mean.
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End-diastolic and end-systolic volumes were smaller in females than in 
males by about 15% for the left and about 25% for the right ventricle (p < 0.01 
for all values). Left and right ventricular masses were larger in males than in 
females (22% for LV mass and 15% for RV mass, p < 0.001 for both). After 
indexing to body surface area, the differences for the left, but not for right 
ventricular volumes, and also for right, but not left, ventricular mass were no 
longer statistically significant. Right ventricular ejection fraction was 7% higher 
in females (p = 0.002) but left ventricular ejection fraction was not significantly 
different (p =0.80).  
The normal values for male and female left and right ventricular 
volumes in older and younger age groups are shown in Table 3.3. In males, 
with increasing age, there were significantly smaller right and left ventricular 
volumes. These differences remained after normalisation to body surface 
area. Left and right ventricular mass and mass indices were also lower with 
increasing age in males. Both left and right ventricular ejection fractions 
significantly increased with increasing age in males (p=0.01 for both). In 
females, only left ventricular end-diastolic volume index was significantly 
different (p=0.03) and stroke volume index showed a trend for smaller values 
with increasing age (p=0.05). 
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Table 3.3: Myocardial mass and function by age and gender 
 Male (n = 63) Female (n = 45) 
 
< 35  
years 
 (n =31) 
≥ 35 
years 
(n =32) 
p 
< 35 
 years 
 (n =23) 
≥ 35 
 years 
 (n =22) 
p 
LV ejection 
fraction (%) 
67 ±5 
(57-77) 
71 ± 6 
(59-83) 0.01 
69±6 
(57-81) 
69 ±6 
(57-81) 0.90 
LV mass (g) 131 ±21 (89-173) 
120 ±23 
(74-166) 0.05 
92±20 
(52-132) 
92 ±19 
(54-130) 0.94 
LV mass index 
(g/m2) 
67 ±10 
(47-87) 
60 ±9 
(42-78) 0.005 
53±9 
(35-71) 
52 ±9 
(34-70) 0.76 
LV end-diastolic 
volume (ml) 
173 ±29 
(115-231) 
149 ±25 
(99-199) 0.001 
137±25 
(87-187) 
128 ±23 
(82-174) 0.23 
LV end-diastolic 
volume index 
(ml/m2) 
90 ±11 
(68-112) 
75 ±11 
(53-97) <0.001 
80±9 
(62-98) 
73 ±11 
(51-95) 0.03 
LV end-systolic 
volume (ml) 
57 ±15 
(27-87) 
43 ±13 
(17-69) <0.001 
43±11 
(21-65) 
40 ±12 
(16-64) 0.30 
LV end-systolic 
volume index 
(ml/m2) 
30 ±7 
(16-44) 
22 ±6 
(10-34) <0.001 
25±6 
(13-37) 
23 ±6 
(11-35) 0.20 
LV stroke volume 
(ml) 
118 ± 18 
(82-154) 
106 ± 19 
(68-144) 0.015 
96 ± 18 
(60-132) 
89 ± 16 
(57-121) 0.19 
LV stroke volume 
index (ml/m2) 
60 ± 8 
(44-76) 
53 ± 8 
(37-69) 0.001 
55 ± 6 
(43-67) 
51 ± 8 
(35-67) 0.05 
RV ejection 
fraction (%) 
57 ±5 
(47-67) 
61 ±6 
(49-73) 0.01 
61±3 
(55-67) 
64 ±7 
(50-78) 0.20 
RV mass (g) 42 ±8 (26-58) 
39 ±7 
(25-53) 0.06 
36±7 
(22-50) 
33 ±7 
(19-47) 0.13 
RV mass index 
(g/m2) 
22 ±4 
(14-30) 
20 ±3 
(14-26) 0.03 
21±3 
(15-27) 
19 ±3 
(13-25) 0.08 
RV end-diastolic 
volume (ml) 
203 ±33 
(137-269) 
181 ±28 
(125-237) 0.006 
152±27 
(98-206) 
140 ±37 
(66-214) 0.23 
RV end-diastolic 
volume index 
(ml/m2) 
104 ±15 
(74-134) 
89 ±11 
(67-111) <0.001 
89±11 
(67-111) 
80 ±19 
(42-118) 0.09 
RV end-systolic 
volume (ml) 
87 ±20 
(47-127) 
71 ±17 
(37-105) 0.001 
59±12 
(35-83) 
52 ±22 
(8-96) 0.23 
RV end-systolic 
volume index 
(ml/m2) 
44 ±9 
(26-62) 
34 ±7 
(20-48) <0.001 
35±5 
(25-45) 
30 ±12 
(6-54) 0.08 
RV stroke volume 
(ml) 
116 ± 19 
(78-154) 
110 ± 18 
(74-146) 0.20 
93 ± 17 
(59-127) 
93 ± 17 
(50-126) 0.33 
RV stroke volume 
index (ml/m2) 
59 ± 9 
(41-77) 
55 ± 8 
(39-71) 0.06 
54 ± 7 
(40-68) 
54 ± 7 
(32-68) 0.15 
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The values for end-diastolic (maximal volume), end-systolic (minimal 
volume), stroke volume and ejection fraction for the left atrium are shown in 
Table 3.4. Males showed significantly larger end-systolic left atrial volumes 
and stroke volumes than females. There was a trend for males to have larger 
end-diastolic left atrial volumes (p = 0.055). There was no significant gender 
difference in left atrial ejection fraction. 
 
Table 3.4: Left atrial (LA) parameters and comparison between males and 
females 
 
 Mean ± SD 
(n=108) 
Males 
mean ± SD 
(n=63) 
Females 
mean ± SD 
(n=45) 
P value 
Maximal LA 
volume (ml) 97 ± 27 103 ± 30 89 ± 21 0.01 
Minimal LA 
volume (ml) 44 ± 13 46 ± 14 41 ± 11 0.055 
LA ejection 
fraction (%) 54 ± 12 55 ± 13 53 ± 9 0.47 
LA stroke volume 
(ml) 53 ± 21 58 ± 23 48 ± 15 0.01 
 
Intraobserver, interobserver and interstudy variability was higher for 
right ventricular compared with the left (Table 3.5). For right and left 
ventricular parameters, intraobserver variability was lowest, followed by 
interobserver and then interstudy variability (Figure 3.2). Variability was 
generally larger for left atrial measurements.  
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Table 3.5: Reproducibility of measurements 
 Intraobserver Interobserver Interstudy 
 
Bias 
(95% Limits 
of 
Agreement) 
CoV 
Bias 
(95% Limits 
of 
Agreement) 
CoV 
Bias 
(95% Limits  
of 
Agreement) 
CoV 
LV EF 0.5 (-2.6 to 3.5) 2.3 
1.6 
(-2.8 to 6.0) 3.3 
0.5 
 (-9.1 to 10.1) 7.5 
LV 
EDVI 
4.6 
(-4.4 to 13.7) 5.6 
0.4 
(-3.8 to 4.6) 2.7 
-1.4 
(-9.7 to 6.9) 5.2 
LV mass 5.4 (-6.8 to 17.5) 6.1 
5.8 
(-4.4 to 16.0) 5.2 
1.8 
(-17.9 to 21.6) 9.4 
RV EF 0.1 (-6.2 to 6.4) 5.3 
-2.8 
(-15.2 to 9.1) 10.7 
1.9 
(-11.48 to 15.2) 11.4 
RV 
EDVI 
-3.2 
(-18.8 to 12.5) 9.0 
-0.1 
(-16.7 to 16.5) 9.6 
0.7 
(-21 to 4.3) 7.4 
LA EF -1 (-18 to 17) 16.4 
4.4 
(-6 to 15) 9.6 
-3 
(-19 to 12) 14.7 
CoV = Coefficient of Variability; LA = left atrial; LV = left ventricular; RV = right ventricular; EF 
= ejection fraction; EDVI = end-diastolic volume index; 
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Figure 3.2: Interstudy reproducibility for LV ejection fraction (LV EF), RV 
ejection fraction(RV EF) and left atrial ejection fraction (LA EF) for 12 healthy 
volunteers (Bland-Altman plot (Bland and Altman, 1986)). Solid lines 
represent the mean (bias) and dotted lines represent the limits of agreement 
(95% limits of agreement). 
3.4 Discussion 
Over the past five years, a number of studies have reported on the use 
of CMR to establish normal values for ventricular function for comparison with 
clinical patients. These have been limited by the use of free-breathing, small 
numbers of subjects over a narrow age range, the focussing on either the left 
or the right ventricle and the use of different acquisition techniques and 
vendors (Lorenz et al., 1999; Sandstede et al., 2000; Grothues et al., 2002; 
Moon et al., 2002; Grothues et al., 2004). 
Recently, the steady-state free precession (SSFP) technique has 
allowed more accurate definition of the endocardial and epicardial borders 
and a shorter acquisition time. 
In this study, we have used this technique to establish a large 
database of ventricular and left atrial volumes in healthy volunteers in a 
single, clinically realistic examination.  
Chapter 3 61 D.Phil. thesis: S.E. Petersen 
 
Our values show volumes, normalised volumes, stroke volumes and 
ejection fractions for the left ventricle similar to Grothues et al (Grothues et al., 
2002; Grothues et al., 2004). However, our right ventricular volumes are 
slightly larger (RVEDV 173± 39 versus 153± 34 ml, RVESV 69± 22 versus 
58± 20ml) and our masses smaller (38±8g versus 60 ± 14g). These 
differences may be explained by the use of segmented FLASH breath-hold 
cines with contiguous 10mm slices on a Picker Edge 1.5 T Marconi system in 
Grothues’ study.  
Lorenz and co-workers published the first normal range of CMR mass 
and volumes (Lorenz et al., 1999). Their data show smaller volumes, which 
may be explained by the use of acquisition with a conventional cine gradient 
echo sequence and the inclusion of children. Moon et al have previously 
shown significantly higher left ventricular volume measurements using SSFP 
imaging when compared with FLASH imaging which is explained as being 
due to better definition of the endocardial and epicardial borders and 
improved basal slice selection (Moon et al., 2002). The normal range 
published by Alfakih using a Phillips 1.5 T breath-hold SSFP sequence with 
6mm slices and a 4 mm interslice gap showed left and right ventricular 
volumes comparable to our study (Alfakih et al., 2003). Left ventricular mass 
index was also similar, males 64.7 ± 9.3g and females 52.0 ± 7.4g compared 
with 62.5 ± 9.0g and 54.6 ± 11.9g in our study. However, our study also 
provides information on right ventricular mass and left atrial volumes and 
function. Furthermore, we have acquired this in a clinically realistic setting 
with three different operators scanning in a larger population of healthy 
volunteers. 
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In the present study, we showed a significant gender difference for left 
and right ventricular volume indices, left ventricular mass index and right 
ventricular ejection fraction. We also demonstrated a significant decrease in 
volume indices of both ventricles with age in males. However, females only 
showed a statistically significant difference in LV end-diastolic volume and left 
ventricular stroke volume indices. These observations closely reflect autopsy 
findings with decreasing left ventricular mass and progressive left ventricular 
myocyte loss with increasing age in males with values remaining constant in 
females (Olivetti et al., 1995). These findings may reflect gender differences 
in ventricular remodelling with increasing age in healthy volunteers 
(Sandstede et al., 2000). Such differences may result from age-related 
hormonal changes, in particular reduced testosterone levels with increasing 
age in males, which may explain the reduced ventricular mass. In animal 
models, supraphysiological testosterone levels have been shown to induce 
cardiac hypertrophy and increases in left ventricular weight (Nahrendorf et al., 
2003). The age-specific gender differences may also be explained by a 
reduction in physical activity with age. Our data suggest that in clinical 
practice, indexed age and sex specific values should be used, particularly in 
males. 
Our results confirm that the interstudy reproducibility is lower for the 
right ventricle than for the left, similar to previous results (Grothues et al., 
2004). This may be explained by the difficulty in defining the most basal slice 
and also in drawing endocardial contours around the increased trabeculations 
and moderator band of the right ventricle. Our volunteers underwent repeat 
scans at least one week apart, appropriately reflecting changes in physiology 
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and ensuring repositioning and replanning. The scans within our study were 
acquired by three operators. This explains why our interstudy variability is 
slightly larger than other studies where subjects underwent repeat scanning 
within 15 minutes by a single operator. However, we feel this acquisition 
reflects real clinical practice more closely. 
Intraobserver and interobserver variability was higher for the right than 
for the left ventricle, again illustrating the complexity of the right ventricle. Our 
variability measurements were comparable to others reported in the literature 
(Lorenz et al., 1999; Rominger et al., 1999). 
Left atrial function is impaired in a number of cardiac conditions, 
including atrial fibrillation, the commonest arrhythmia. Echocardiographic 
methods of measuring the left atrium rely on geometric assumptions and are 
user-dependent. The standard acquisition of left atrial volumes and ejection 
fraction with CMR uses the short-axis stack for which both acquisition and 
post-processing is time-consuming (Sievers et al., 2004). The biplane area-
length method has previously been shown to correlate well with the short axis 
stack, and to be significantly faster, but it requires geometric assumptions 
similar to echocardiography (Matsuoka et al., 1993; Sievers et al., 2004). It 
also relies upon the use of pilot images acquired to optimise left ventricular 
imaging rather than primarily focussing on the left atrium in these views. 
Our left atrial ejection fractions are similar to those previously reported. 
However, there was a high interobserver variability of these left atrial 
measurements, reflecting the difficulty in drawing contours, particularly when 
including the left atrial appendage but excluding the pulmonary veins. A small 
Chapter 3 64 D.Phil. thesis: S.E. Petersen 
 
difference between observers in drawing contours or measuring the left atrial 
length will have a large effect on left atrial volume when using the biplane 
area-length method. However, the left atrial ejection fraction variability was 
acceptable. The interstudy reproducibility for the left atrial measurements was 
again relatively low, reflecting the additional dependence of the volumes on 
slice positioning and variable cardiac physiology. However, when using 
comparable values to those in the literature, our reproducibility values 
compare favourably (Sievers et al., 2004). 
We have shown the normal range of left atrial volumes, stroke volumes 
and ejection fraction using the biplane area-length method in healthy 
volunteers. These data are routinely obtained from a clinical scan and hence 
provide a normal range of values for a time-saving method of acquiring left 
atrial volumes. However, in view of the high observer variability, we would 
recommend the use of an additional short-axis method for a more 
reproducible and accurate assessment of the left atrium when this is clinically 
required. 
Conclusion 
We have produced a large database for left and right ventricular and 
left atrial volumes of healthy volunteers using SSFP images at 1.5 T. This will 
be of particular use for reference in both clinical and research studies. 
We have shown significantly different volumes with gender, and 
significant differences in age-specific left and right ventricular volumes, mass 
and ejection fraction in males but not in females. We have also demonstrated 
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the use and limitations of the biplane area-length method to acquire left atrial 
volumes and ejection fraction.
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CHAPTER 4: Three-dimensional myocardial tissue motion – 
quantitative regional wall motion analysis in healthy 
volunteers using cine phase contrast velocity magnetic 
resonance imaging 
4.1 Introduction  
Assessment of myocardial regional wall motion plays a key role in 
many diagnostic and therapeutic decisions in current clinical practice. Studies 
of both stress induced ischemia and of viability, i.e. high dose and low dose 
dobutamine stress echocardiography (Mazur and Nagueh, 2001), 
respectively, or cardiovascular magnetic resonance imaging (Nagel et al., 
1999) (CMR), are based on regional wall motion analysis. Semi-quantitative 
grading of regional wall motion is the most frequently applied technique, but is 
highly subjective with limited reproducibility. Despite dramatic improvements 
in echocardiography and CMR technology, permitting quantitative and 
objective regional wall motion analysis, none has yet been widely applied in 
clinical practice. A possible explanation for this is that no existing single 
technique has yet provided non-invasive, quantitative, reproducible, three-
dimensional, systolic and diastolic regional wall motion analysis with sufficient 
spatial resolution to identify transmural variation (endo- and epicardial 
differences) in all myocardial segments (Cerqueira et al., 2002). 
Tissue doppler, strain and strain-rate imaging using echocardiography 
are highly dependent on transducer angulation and have, thus, inherent 
limitations regarding complete, three-dimensional myocardial coverage and 
reproducibility (Pellerin et al., 2003; Voigt and Flachskampf, 2004). CMR 
offers different techniques for regional wall motion analysis: myocardial 
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tagging (Zerhouni et al., 1988; Maier et al., 1992; McVeigh and Atalar, 1992; 
Rademakers et al., 1994; Young et al., 1994a; Young et al., 1994b; Reichek, 
1999; Henson et al., 2000), phase velocity (‘tissue phase mapping’) 
(Karwatowski et al., 1994a; Pelc et al., 1994; Hennig et al., 1998a; Hennig et 
al., 1998b; Markl et al., 1999; Henson et al., 2000; Markl and Hennig, 2001; 
Markl et al., 2002), phase displacement (Aletras et al., 1999a; Aletras et al., 
1999b; Kim et al., 2004), and optical flow methods (Amartur and Vesselle, 
1993). Tagging approaches deliberately obliterate lines or grids of signal and 
watch grid deformation as these regions move during the cardiac cycle. 
Phase velocity based methods directly observe the velocity of the tissue using 
the phase of the signal, hence the term ‘tissue phase mapping’, and can 
determine the displacement by integration over time. Traditionally, tissue 
phase mapping methods have measured the displacement over short time 
intervals yielding measurements of instantaneous velocity, this interval can be 
extended with use of the displacement encoding with stimulated echos 
(DENSE) approach (Aletras et al., 1999a; Aletras et al., 1999b; Kim et al., 
2004) that allows it to measure displacements over most of the cardiac cycle. 
Optical flow provides an alternative approach for defining cardiac velocities 
and displacements and uses high-resolution cine MR images that are not 
encoded with additional displacement information. Computerized algorithms 
are used to generate motion fields that explain the evolution of the images 
from one frame to the next. Such an approach is an extension of the method 
that is performed naturally by the human brain (Amartur and Vesselle, 1993). 
We hypothesized that tissue phase mapping would allow quantitative 
measurements of motion parameters which are reproducible and independent 
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of analysers. Further, given the high resolution of tissue phase mapping, we 
hypothesized that this method would show differences between endo- and 
epicardium for radial, circumferential and longitudinal velocity parameters in 
healthy volunteers. Thus, the purpose of our study was to establish 
prospectively a database of normal, three-dimensional, systolic and diastolic, 
endo- and epicardial velocities of all myocardial segments in healthy 
volunteers using cine phase contrast velocity magnetic resonance imaging 
(tissue phase mapping or TPM). 
Study participants 
96 healthy volunteers (mean±SD age=38±12 years, 57 (59%) men) 
with normal electrocardiograms were enrolled to undergo CMR imaging. The 
mean±SD age of males (n=57; 39±13 years) was similar to females (n=39; 
37±12 years) (p>0.05). None of the subjects indicated a history of 
cardiovascular disease, diabetes, cardiovascular symptoms or chronic 
medication other than contraceptives. The study was carried out according to 
the principles of the Declaration of Helsinki and was approved by our 
institutional ethics committee. Each subject gave informed written consent. 
Baseline characteristics of the healthy volunteers are given in Table 4.1. 
4.2 Methods 
MR imaging 
Acquisition of SSFP cine images and of tissue phase mapping data are 
described in detail in chapter 2. All acquired datasets were of sufficient image 
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quality, without respiration artefacts in the magnitude images, and could be 
included in the analysis (Figure 4.1). 
A B
 
Figure 4.1: End-diastolic (A) and end-systolic (B) magnitude images at mid-
ventricular level in a healthy volunteer using a black blood k-space 
segmented gradient echo sequence (tissue phase mapping). 
The first consecutive 18 of 96 healthy volunteers were scanned twice 
within one week to determine the inter-study reproducibility. The mean ± SD 
of males (n=8; 36 ± 15 years) was similar to females (n=10; 37 ± 14 years) 
(p>0.05). These 18 repeat sets of tissue phase mapping data were acquired 
with an initial sequence providing only radial and circumferential velocity 
information. Consequently, no variability information was available for 
longitudinal velocity and strain-rate. 
Data Analysis 
Cine images were analyzed manually as described in detail in chapter 
2. For each set of cine studies, standard LV volume parameters were 
generated to further document normalcy of the volunteers (Table 4.1): LV 
ejection fraction (LVEF), LV mass index, LV end-diastolic (LVEDVI), end-
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systolic (LVESVI) and stroke volume index (LVSVI). All parameters were 
within normal limits. TPM data analysis was performed on a personal 
computer using customized software programmed in Matlab Version 6.5 (The 
Mathworks Inc., Natick, MA) as described in chapter 2 (Markl et al., 2002). 
One observer analysed the first 18 volunteer images twice, after a 6 months 
gap, and these data were also analysed by a second observer to allow intra- 
and inter-observer variability, respectively. 
Statistical Analysis 
All data are presented as mean ± standard deviation (SD) unless 
stated otherwise. To establish differences for continuous data between the 
base, the mid-ventricle and the apex and to compare endo- and epicardial 
parameters (transmural gradient), mixed effects models were fitted in STATA 
8.0 (StataCorp LP, College Station, Texas US), with a random intercept for 
volunteer and categorical fixed effects for sector and transmural gradient. 
Throughout the analyses, a two-sided p-value of <0.05 was considered 
statistically significant. 
For inter-study reproducibility, inter- and intra-observer variability the 
mean difference ± the standard deviation of the mean difference were 
determined (Bland and Altman, 1986). All other computations were done with 
SPSS 11.5 (SPSS Inc., Chicago, US) and Matlab Version 6.5 (The 
Mathworks Inc., Natick, MA). 
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Table 4.1: Baseline characteristics and left ventricular volume results. 
Normal range for males (m) and females (f) in brackets (Alfakih et al., 2003). 
 Mean ± SD (n=96) 
Age [years] 38 ± 12 
Gender 57 male/ 39 female 
Height [cm] 174 ± 8 
Weight [kg] 73.0 ± 12.9 
Body surface area [m2] 1.87 ± 0.19 
Heart rate [bpm] 65 ± 10 
Systolic blood pressure [mmHg] 123 ± 18 
Duration of systole [ms] 324 ± 34 
Diastolic blood pressure [mmHg] 81 ± 17 
LV ejection fraction [%] 69 ± 6 (m: 55-73; f: 54-74) 
LV mass index [g/m2] 58.7 ± 10.5 (m: 46-83; f: 37-67) 
LV end-diastolic volume index 
[ml/m2] 
80 ± 12 (m: 53-112; f: 56-99) 
LV end-systolic volume index [ml/m2] 25 ± 7 
LV stroke volume index [ml/m2] 55 ± 8 
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4.3 Results 
Radial velocity 
Contraction (positive radial velocities) and expansion (relaxation, 
negative radial velocities) patterns in the base, at mid-ventricular and apical 
level were characterized by an increase in contraction velocity during early 
systole, followed by a slowing down of contraction velocity later in systole. 
The inverse pattern was observed in diastole. Similarly, an initial increase in 
radial expansion velocities was followed by a decrease later during diastole 
(Figure 4.2). Systolic peak radial velocity was lowest in the apex (mixed 
effects model z=-10.38, p<0.001), but the systolic time to peak radial velocity 
was similar at all levels (z=-1.21, p=0.23., Table 4.2, Figure 4.3). The 
diastolic time to peak radial velocity was shorter in the basal compared to the 
mid-ventricular and to the apical slices (z=8.44, p<0.001), which was 
accompanied by similar diastolic peak radial velocities at those myocardial 
levels (z=0.35, p=0.73). Transmural gradients for systolic and diastolic peak 
radial velocities could be observedin each myocardial slice (p<0.001 across 
levels for both systolic and diastolic velocities) with higher endo- than 
epicardial velocities (Figure 4.3). 
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Figure 4.2: Three-dimensional tissue phase mapping of basal (top row), 
mid-ventricular (middle row) and apical short axis views (bottom row). Graphs 
are presented as mean (solid line) ± SD (dashed lines) after piecewise cubic 
Hermite interpolation. Panels A, D and G show radial velocity (n=96) 
information with positive velocities representing contraction and negative 
velocities expansion. Panels B, E and H display circumferential velocities 
(n=96) with positive velocities representing clockwise rotation and negative 
velocities counter-clockwise rotation. Panels C, F and I plot longitudinal 
velocities (n=78) with positive velocities indicating base movement away from 
the apex and negative velocities showing base movement towards the apex. 
Longitudinal velocities during the cardiac cycle can be divided into 5 steps: 
The base of the heart undergoes an initial displacement towards the apex (1) 
followed by a velocity drop (2). At end-systole a small increase in velocity 
directed towards the apex occurs (3) before rapid motion of the base away 
from the apex during early diastole (4). This is followed by a rapid decrease in 
velocity (5). 
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Figure 4.3: Segmental and myocardial layer distribution of radial velocity 
parameters (n=96). Segments 1-6 are basal, 7-12 mid-ventricular and 13-16 
apical according to the AHA/ACC recommendation (Cerqueira et al., 2002). 
Epicardial (solid squares) and endocardial (circles) velocity parameters are 
shown as mean ± standard error of the mean. Positive radial velocities 
indicate contraction and negative radial velocities expansion. Transmural 
gradients for systolic and diastolic peak radial velocities are observed in each 
of the three myocardial levels (p<0.001 for both) with higher absolute endo- 
than epicardial velocities. The basal, mid-ventricular and apical slices were 
located at 28 ± 5%, 51 ± 4% and 74 ± 5%, respectively. 
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Table 4.2: Mean±SD segmental and myocardial layer distribution of radial 
and longitudinal velocity parameters 
 Basal Mid Apical Basal Mid Apical 
Systolic peak radial velocity 
[cm/s] 
Diastolic peak radial velocity 
[cm/s] 
Epicardium 2.97±1.22 3.09±1.27 2.57±0.96 -3.52±1.71 -3.72±1.54 -3.36±1.37 
Endocardium 3.92±1.26 3.83±1.12 3.22±0.94 -4.62±2.13 -5.05±1.80 -4.61±1.56 
Transmural 3.44±1.33 3.46±1.25 2.90±1.00 -4.07±2.01 -4.38±1.80 -3.98±1.60 
Systolic time to peak radial velocity 
[%ES] 
Diastolic time to peak radial velocity 
[%ED] 
Epicardium 47.8±29.9 48.0±25.3 46.0±20.8 21.7±11.2 23.1±11.1 26.0±11.5 
Endocardium 48.3±25.6 47.4±18.5 47.4±16.1 21.5±10.5 21.4±11.7 25.6±9.56 
Transmural 48.1±27.8 47.7±22.1 46.7±18.6 21.6±10.8 22.2±11.4 25.8±10.6 
 
 Basal Mid Apical Basal Mid Apical 
Systolic peak longitudinal velocity 
[cm/s] 
Diastolic peak longitudinal velocity 
[cm/s] 
Epicardium -5.59±2.73 -4.14±3.01 -2.66±2.71 9.25±3.04 6.94±2.80 4.27±2.49 
Endocardium -5.65±2.61 -4.11±2.82 -2.71±2.65 9.59±3.18 7.28±2.80 4.35±2.45 
Transmural -5.62±2.67 -4.12±2.92 -2.68±2.68 9.42±3.11 7.11±2.80 4.31±2.47 
Systolic time to peak longitudinal velocity 
[%ES] 
Diastolic time to peak longitudinal 
velocity [%ED] 
Epicardium 37.3±38.8 50.6±61.0 64.4±67.4 21.7±7.36 22.7±8.19 15.2±17.7 
Endocardium 38.4±41.8 54.4±62.8 65.5±67.2 21.5±7.54 22.2±8.90 11.7±19.4 
Transmural 37.9±40.3 52.5±61.9 65.0±67.3 21.6±7.45 22.4±8.55 13.4±18.7 
 
Circumferential velocity and torsion-rate 
During systole, a counter-clockwise rotation (negative velocities in 
Figure 4.2) as viewed from the apex was followed by a clockwise rotation 
(positive velocities in Figure 4.2) in the base and at mid-ventricular level. The 
apical myocardium, however, showed a counter-clockwise rotation during the 
entire length of systole. Circumferential velocities were generally lower during 
diastole. The base revealed a counter-clockwise rotation in contrast to a 
clockwise rotation in the apex during diastole. Consequently, peak velocities 
and time to peak parameters for clockwise and counter-clockwise rotation 
were systolic or diastolic depending on the location of the myocardial 
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segments. Therefore, we plotted the torsion-rate over the cardiac cycle 
(Figure 4.4a). A relative counter-clockwise rotation during systole was 
followed by a relative clockwise rotation of the apex against the base. Peak 
systolic torsion-rate, peak diastolic torsion-rate, systolic time to peak torsion-
rate, diastolic time to peak torsion-rate are shown in Table 4.3. 
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Figure 4.4: A: Myocardial torsion-rate (n=96). Graphs are presented as 
mean (solid line) and 1x SD (dashed lines) after piecewise cubic Hermite 
interpolation. A relative counter-clockwise rotation during systole is followed 
by a relative clockwise rotation of the apex against the base. B: Myocardial 
longitudinal strain-rate (n=78). Basal movement towards the apex occurs 
during systole and away from the apex during diastole. ED=end-diastole, 
ES=end-systole.
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Table 4.3: Mean ± SD myocardial torsion-rate and longitudinal strain-rate 
in 96 healthy volunteers 
Peak systolic torsion-rate [deg.s-1.cm-1] (n=96) 16.2 ± 4.7 
Time to peak systolic torsion-rate [%ES, i.e. time 
from R-wave/time from R-wave to ES] (n=96) 
53 ± 21 
Peak diastolic torsion-rate [deg.s-1.cm-1] (n=96) - 15.0 ± 5.7 
Time to peak diastolic torsion-rate [%ED, i.e. time 
from ES to time from ES to R-wave] (n=96) 
13 ± 8 
Peak systolic longitudinal strain-rate [s-1] (n=78) - 1.09 ± 0.32 
Time to peak systolic longitudinal strain-rate [%ES, 
i.e. time from R-wave/time from R-wave to ES] (n=78) 
51 ± 13 
Peak diastolic longitudinal strain-rate [s-1] (n=78) 1.49 ± 0.60 
Time to peak diastolic longitudinal strain-rate [%ED, 
i.e. time from ES to time from ES to R-wave] (n=78) 
23 ± 8 
 
No statistically significant differences between endo- and epicardial 
velocities were observed for clockwise and counter-clockwise peak velocities 
and time to peak circumferential velocities (p>0.05 for all). 
Longitudinal velocity and longitudinal strain-rate 
Longitudinal velocities during the cardiac cycle could be divided into 5 
steps (numbers of steps in brackets correspond to those in Figure 4.2): The 
base of the heart underwent an initial displacement towards the apex (1, peak 
systolic longitudinal velocity -5.3 ± 2.0 cm/s) followed by a velocity drop (2). At 
end-systole a small increase in velocity directed towards the apex occurred 
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(3) before rapid motion of the base away from the apex during early diastole 
(4, peak diastolic longitudinal velocity 9.2 ± 2.5 cm/s). This was followed by a 
rapid decrease in velocity away from the apex (5). The same pattern of 
motion was present at the mid-ventricular (peak systolic and diastolic 
longitudinal velocities -3.7± 2.1 and 7.0 ± 2.3 cm/s, respectively) and apical 
level (peak systolic and diastolic longitudinal velocities -2.2 ± 2.1 and 4.1± 2.0 
cm/s, respectively) with decreasing amplitudes. Maximal basal movement 
towards the apex occurred during systole and away from the apex during 
diastole (Figure 4.4b). 
Systolic peak (z=-0.25, p=0.81) and time to peak (z=1.04, p=0.30) 
longitudinal velocities were similar in the endocardial and epicardial layers, 
while diastolic peak (z=3.12, p=0.002) and time to peak (z=-2.72, p=0.006) 
longitudinal velocities differed. Both diastolic (z=-44.64, p<0.001) and systolic 
(z=27.11, p<0.001) peak longitudinal velocities decreased from base to apex 
(Table 4.2, Figure 4.5). 
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Figure 4.5: Segmental and myocardial layer distribution of longitudinal 
velocity parameters (n=78). Segments 1-6 are basal, 7-12 mid-ventricular and 
13-16 apical according to the AHA/ACC recommendation (Cerqueira et al., 
2002). Epicardial (solid squares) and endocardial (circles) velocity parameters 
are shown as mean ± standard error of the mean. Positive longitudinal 
velocities indicate base movement away from the apex and negative values 
base movement towards the apex. Systolic peak (z=-0.25, p=0.81) and time 
to peak (z=1.04, p=0.30) longitudinal velocities were similar in the endocardial 
and epicardial layers, while diastolic peak (z=3.12, p=0.002) and time to peak 
(z=-2.72, p=0.006) longitudinal velocities differed. Both diastolic (z=-44.64, 
p<0.001) and systolic (z=27.11, p<0.001) peak longitudinal velocities 
decreased from base to apex. 
Inter- and intra-observer variability and inter-study reproducibility 
Intra-observer and inter-observer variability were low and inter-study 
reproducibility was high for all velocity parameters at apical, mid-ventricular 
and basal level (Table 4.4 and Figure 4.6). 
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Figure 4.6: Intra- and inter-observer variability and inter-study reproducibility 
for radial and circumferential velocities during the cardiac cycle at mid-
ventricular level shown as the mean for the first 18 consecutive healthy 
volunteers. Observer 1, measurement 1 (solid line), observer 1, measurement 
2 (dashed-dotted line), observer 2 (dashed line) and second scan (dotted 
line). Note the small variation in systolic and diastolic peak velocities and 
systolic and diastolic time to peak velocities. ED=end-diastole, ES=end-
systole. 
 Table 4.4: Intra-and inter-observer variability and inter-study reproducibility at basal, mid-ventricular and apical level 
 Healthy volunteers 
(mean for n=18) 
Intra-observer 
variability 
Inter-observer 
variability 
Inter-study 
reproducibility 
Systolic peak radial 
velocity [cm.s-1] 
basal  
mid 
apical 
2.70±0.63 
2.94±0.71 
2.40±0.75
-0.009±0.17 
-0.07±0.29 
-0.04±0.13 
0.02±0.13 
0.005±0.31 
0.02±0.13
-0.003±0.59 
-0.12±0.84 
0.18±0.76
Diastolic peak radial 
velocity [cm.s-1] 
basal  
mid 
apical 
-3.05±1.06 
-3.88±1.33 
-4.03±1.33
-0.04±0.37 
-0.10±0.25 
-0.08±0.17 
-0.05±0.36 
-0.06±0.21 
0.04±0.13
-0.72±1.46 
-0.76±1.84 
-0.37±1.55
Clockwise peak 
circumferential velocity 
[cm.s-1] 
basal  
mid 
apical 
2.48±0.55 
1.61±0.69 
1.80±0.66
-0.16±0.34 
-0.04±0.41 
0.02±0.11 
0.04±0.11 
-0.05±0.23 
0.05±0.13
0.51±1.03 
0.29±0.87 
0.14±0.87
Counter-clockwise peak 
circumferential velocity 
[cm.s-1] 
basal  
mid 
apical
-2.55±1.03 
-2.99±1.37 
-2.97±1.31
-0.14-0.65 
0.02±0.49 
-0.03±0.09 
-0.006±0.10 
-0.03±0.24 
0.04±0.12
-0.22±1.43 
-0.72±1.18 
-0.56±1.12
Peak systolic torsion-rate  
[deg.s-1.cm-1] 
12.6±.4.6 0.3±1.1 0.2±0.6 0.1±5.7 
Peak diastolic torsion-rate 
[deg.s-1.cm-1] 
-14.3±5.7 0.2±1.1 -0.1±0.6 -3.4±7.4 
Variability and reproducibility data are presented as mean difference ± standard deviation. 
Chapter 4 82 D.Phil. thesis: S.E. Petersen 
4.4 Discussion 
Both of the mature CMR based methods, tagging and tissue phase 
mapping essentially evaluate myocardial motion. Tissue phase mapping 
offers the better spatial resolution, whereas tagging has a better temporal 
resolution and may thus be superior in terms of identifying peak deformation. 
Tissue phase mapping covers most of the cardiac cycle allowing for 
quantification of endo- and epicardial wall motion in both systole and a large 
portion of diastole with consistent data quality, whereas tag fading prevented 
diastolic motion assessment until newer tagging sequences were introduced. 
Tissue phase mapping data acquisition and post-processing are quick and 
simple in contrast to the time-consuming tagging analysis, although the latter 
is continually being improved (Osman et al., 1999; Garot et al., 2000). The 
temporal resolution for tissue phase mapping could potentially be improved 
with a navigator sequence, although such an approach would remove the 
need for breath-holding, but might increase the total scan time. Within the 
temporal resolution applied in our study population, no dependency was 
found for peak systolic and diastolic mid-ventricular radial velocity suggesting 
that the current range of temporal resolution for tissue phase mapping might 
be sufficient. 
Typical transmural radial velocity patterns in healthy hearts have been 
described by Markl and co-workers using tissue phase mapping (Markl et al., 
2002) and are in keeping with our findings. In addition, we report transmural 
differences with higher systolic and diastolic endo- than epicardial radial 
velocities. Hashimoto and colleagues found an increase in systolic and 
diastolic strain-rate from endocardium to mid-myocardium to epicardium in an 
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animal model, but did not observe significant differences in myocardial 
velocities using tissue doppler imaging (Hashimoto et al., 2003). This 
discrepancy might be partly explained by the slightly better spatial resolution 
for tissue phase mapping (2.7 x 1.3 mm for TPM vs. <3 x <2 mm for tissue 
doppler imaging (Hashimoto et al., 2003)) and more likely by the fact that our 
study only compared two rather than three myocardial layer velocities. The 
lower systolic peak radial velocities at the apex might reflect the fact that the 
this region is constrained by the diaphragm. Smaller diastolic peak radial 
velocities in the basal compared to the mid-ventricular and apical myocardium 
might be explained by the proportionally smaller myocardium-to-cavity area at 
the base of the heart. 
Our findings of a counter-clockwise rotation followed by a clockwise 
rotation in the base of the heart during systole and the apical counter-
clockwise rotation during the entire length of systole as viewed from the apex 
are consistent with reports using CMR tagging (Moore et al., 2000). This 
pattern of circumferential velocity in the myocardium is responsible for the fact 
that peak circumferential clockwise and counter-clockwise velocities occur 
quite variably during either systole or diastole. Plotting the “torsion-rate” as 
the difference between the basal and apical circumferential velocities by 
normalizing by the distance between these slices, we obtain the basic system 
independent measure of this motion. This allows determination of true systolic 
and diastolic parameters, such as peak systolic torsion-rate, time to peak 
systolic torsion-rate, peak diastolic torsion-rate and time to peak diastolic 
torsion-rate. We did not find a transmural gradient of circumferential velocities 
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which is in keeping with three-dimensional tagging results reported by Moore 
and colleagues (Moore et al., 2000). 
Our diastolic peak longitudinal velocity at the myocardial base (9.2 ± 
2.5 cm/s) results match basal longitudinal velocities reported by Karwatowski 
et al (Karwatowski et al., 1994b) using tissue phase mapping (8.2 ± 2.2 cm/s). 
Similarly, the decrease in longitudinal velocities from base to apex observed 
in our cohort is confirmed by a previous echocardiography study (Peak 
systolic and diastolic longitudinal velocities at base (-9.3 ± 1.3 and 14.8 ± 3.2 
cm/s, respectively) and mid-ventricular (-7.7 ± 1.6 and 12.3 ± 2.8 cm/s, 
respectively)) (Galiuto et al., 1998). Longitudinal velocities were generally 
smaller using tissue phase mapping compared to echocardiography, which 
might be explained by the better temporal resolution. Surprisingly, we could 
not detect a statistically significant transmural gradient for peak systolic 
longitudinal velocities, although longitudinally directed fibres are mainly 
located in the subendocardium (Rushmer et al., 1953; Simpson, 1997). A 
possible explanation might lie in the helical orientation of the epicardial fibres 
(Torrent-Guasp et al., 1997), potentially only inhibiting systolic transmural 
velocity differences, as peak diastolic longitudinal velocities were greater in 
the endocardial layers. 
Our results suggest that tissue phase mapping is a reproducible, 
comprehensive modality to assess regional wall motion, and intra- and inter-
observer variabilities are low. A previous report has suggested high 
reproducibility assessing patients twice but within the same scan for 
longitudinal velocities (Karwatowski et al., 1994b). The variation seen in true 
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inter-study reproducibility, however, should not only reflect variability in 
measurement, but also varying pre-load, blood pressure and different slice 
selection, which necessitates separate scans. The variability in slice 
positioning in our study population was very low (≤ 5%, standard deviation of 
position/distance from apex to mitral valve plane). Inter-observer variability 
found in our study compares favourably with those obtained for 
echocardiographic strain and strain-rate imaging ( in the order of 15%) (Voigt 
et al., 2000). 
Limitations 
Our study was performed in young healthy volunteers and was not 
designed to investigate effects of age, pre-load and medication on myocardial 
velocities. The effects on the described parameters will have to be addressed 
in future studies. 
Tissue phase mapping is currently limited by a lower temporal 
resolution when compared to echocardiographically determined strain and 
strain-rate (Pellerin et al., 2003) (one order of magnitude) and CMR tagging 
(Moore et al., 2000) (2- to 3-fold). Furthermore, the prospectively triggered 
tissue phase mapping naturally misses about 10-20% of the cardiac cycle in 
late diastole. Higher field-strength magnets, improved gradient systems and 
implementation of parallel imaging may further improve temporal resolution. 
An inherent problem in using myocardial velocity parameters is caused 
by the nature of continuous structures, such as the myocardium, to transmit 
deformation to adjacent tissue, often referred to as “tethering”. Any locally 
measured myocardial velocity might reflect active or passive motion (Urheim 
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et al., 2000; Abraham et al., 2002; Kukulski et al., 2002). As described in 
detail elsewhere (Hennig et al., 1998b), tissue phase mapping is acquired in 
breath-hold to avoid bulk motion of the internal organs and it corrects for in-
plane translational motion. Furthermore, our measures of torsion-rate and 
longitudinal strain-rate are independent of tethering effects. 
Conclusions 
Tissue phase mapping is a reproducible, comprehensive modality to 
assess regional wall motion, and intra- and inter-observer variabilities are low. 
Our results may potentially serve as a reference with which abnormal hearts 
can be compared, allowing tissue phase mapping to be used as part of a 
multi-parametric CMR approach in clinical practice. 
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CHAPTER 5: Sex-specific characteristics of cardiac function, 
geometry and mass in young adult elite athletes 
5.1 Introduction 
Principal differences between male and female hearts are at least 
partly a reflection of the sex specific hormonal milieu (Silver, 1991). 
Experimental studies suggest opposing modulating effects of oestrogen and 
testosterone, with oestrogen having an anti-proliferative and testosterone a 
proliferative stimulus in situations of cardiac remodelling (Marsh et al., 1998; 
Xin et al., 2002; Cavasin et al., 2003; Nahrendorf et al., 2003; Babiker et al., 
2004; Pedram et al., 2005; Skavdahl et al., 2005). However, recent molecular 
studies have indicated a fundamental difference in calcium-sensitive 
signalling pathways leading to pathological vs. physiological hypertrophy 
(McMullen et al., 2003). Little data exist for sex-specific effects on chronic 
physiological cardiac remodelling. Athlete’s heart represents a physiological 
adaptation either to pressure- (strength-trained athletes) or volume-overload 
(endurance-trained athletes), leading to concentric or eccentric LV 
hypertrophy, respectively. Most sport disciplines yield a combination of both 
mechanisms (Morganroth et al., 1975; Pelliccia et al., 1991; Maron et al., 
1995; Pelliccia et al., 1999; Pluim et al., 2000; Maron, 2003; Whyte et al., 
2004b). In the literature, female athletes have typically been 
underrepresented: Recent meta-analyses included male athletes in 59 studies 
and female athletes in only 13 studies (Pluim et al., 2000; Whyte et al., 
2004a). Furthermore, little data exist addressing the degree of right ventricular 
adaptive changes to exercise training, mainly due to the limited 
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echocardiographic access to the right ventricle (Scharhag et al., 2002; 
D'Andrea et al., 2003a; D'Andrea et al., 2003b). 
Cardiac magnetic resonance (CMR) provides high image quality and is 
intrinsically three-dimensional, not relying on geometric assumptions, and is, 
thus, the currently accepted gold-standard method for the measurement of 
both LV and RV cardiac volumes and mass (Bellenger et al., 2000). CMR 
phase velocity imaging (‘tissue phase mapping’) allows three-dimensional 
assessment of cardiac contraction and relaxation with good inter-study 
reproducibility (chapter 4). We aimed to study male and female young adult 
elite athletes with age- and sex-matched sedentary controls to assess sex-
specific differences for LV and RV dilatation and hypertrophy as well as for LV 
contraction and relaxation. We hypothesized that structural and functional 
adaptive changes to exercise training would be sex-specific. 
5.2 Methods 
Study Population 
23 male elite athletes (mean age 25±4 years, training 22±7 hours/week 
in rowing, swimming or triathlon) and 20 female elite athletes (mean age 24±4 
years, training 19±5 hours/week in rowing, swimming or triathlon) and age- 
and sex-matched sedentary healthy controls (21 male, mean age 26±3 years 
and 17 female, mean age 26±3 years) were enrolled into the study. None of 
the subjects had any of the following: history of cardiac disease, hypertension 
or other cardiac risk factors. All sedentary controls had normal 
electrocardiograms (ECG) and no athlete presented with pathological ECG 
changes other than voltage criteria for LV hypertrophy. Subjects with 
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contraindications for CMR were not enrolled. The study was carried out 
according to the principles of the Declaration of Helsinki and was approved by 
our institutional ethics committee. Each subject gave informed written 
consent. 
Cardiovascular Magnetic Resonance Imaging Protocol 
Details of the SSFP cine imaging and tissue phase mapping protocol 
are given in chapter 2. All acquired datasets were of sufficient image quality, 
without respiration artefacts in the magnitude images, and could be included 
in the analysis.  
Image Analysis 
LV and RV volumes, masses and ejection fractions were determined 
as outlined in chapter 2. 
For each of the radial and longitudinal velocities, two systolic and two 
diastolic parameters were computed: systolic peak velocity, systolic time to 
peak velocity, diastolic peak velocity and diastolic time to peak velocity. These 
parameters were computed for averaged global mid-ventricular velocities. In 
addition, the relative speed of motion between the basal and apical slice was 
plotted over the cardiac cycle as the difference between the circumferential 
(torsion-rate [rad.s-1.cm-1] defined as the rate of change of angular velocity 
along the heart) and longitudinal (longitudinal strain-rate [s-1]) velocities of the 
global basal and apical slices normalized to mid-ventricular short axis 
diameter and to ventricular length. Peak systolic torsion-rate, peak diastolic 
torsion-rate, systolic time to peak torsion-rate, diastolic time to peak torsion-
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rate and peak systolic longitudinal strain-rate, peak diastolic longitudinal 
strain-rate, systolic time to peak systolic longitudinal strain-rate and diastolic 
time to peak longitudinal strain-rate were then derived from those graphs. 
Statistical Analysis 
All data are presented as mean ± standard deviation (SD) unless 
stated otherwise. A univariate general linear model with fixed effects for sex 
and training (athlete vs. sedentary control) was used to test whether 
differences between age-and sex-matched athletes and sedentary controls 
were sex-specific. Throughout the analyses, a two-sided p-value of <0.05 was 
considered statistically significant. All computations were performed with 
SPSS 11.5 (SPSS Inc., Chicago, US).  
5.3 Results 
Study population 
Sedentary controls were well matched to elite athletes with regards to 
age, weight, body mass index, body surface area and systolic blood pressure. 
Athletes had a slower heart rate than sedentary controls (p for training =0.01). 
The decrease in diastolic blood pressure observed in male athletes (75±7 
mmHg) compared to male controls (64±9 mmHg) was sex-specific and was 
not observed in females (p for interaction =0.014). Baseline characteristics of 
all subjects are shown in Table 5.1. 
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Table 5.1: Baseline Characteristics of elite athletes and sedentary healthy 
controls. 
 
 Male Female P value 
 Sedentary (n=21) 
Athletes 
(n=23) 
Sedentary
(n=17) 
Athletes 
(n=20) Training Sex Interaction 
Weight (kg) 80±11 79±12 63±10 66±6 0.61 <0.001 0.38 
Height (cm) 182±6 185±10 169±5 174±5 0.03 <0.001 0.58 
BMI (kg/m2) 24.1±3.2 23.1±2.8 21.9±2.9 21.9±1.9 0.43 0.007 0.39 
BSA (m2) 2.01±0.15 2.01±0.20 1.72±0.16 1.79±0.10 0.26 <0.001 0.37 
Training 
(hours/week) N/A 22±7 N/A 19±5 N/A 0.15 N/A 
Training 
(years at elite 
level) 
N/A 9±5 N/A 9±5 N/A 0.70 N/A 
Systolic blood 
pressure 
(mmHg) 
121±8 117±8 111±8 115±10 0.70 0.003 0.07 
Diastolic blood 
pressure 
(mmHg) 
75±7 64±9 66±4 66±8 0.008 0.12 0.014 
Mean blood 
pressure 
(mmHg) 
91±7 82±7 81±4 82±8 0.06 0.02 0.009 
Heart rate 
(bpm) 63±10 61±9 66±10 56±9 0.01 0.60 0.11 
 
Left and right ventricular volumes, mass and global function 
When compared to sedentary controls, athletes, as expected, had 
significantly increased left and right ventricular end-diastolic, end-systolic and 
stroke volumes and mass indices (Figure 5.1), reflecting a training effect of 
15 to 42%. In contrast, LV and RV ejection fractions remained unchanged. 
We observed increased LV and RV volume indices in male compared to 
female subjects, but none of the parameters for LV and RV volumes, mass 
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and ejection fraction showed any sex-specific changes to exercise training 
(p>0.05 for all interactions, Table 5.2). 
A
B
 
Figure 5.1: End-diastolic still frames of steady-state free precession cines in 
a male sedentary control (A: Body surface area 1.84 m2, LV end-diastolic 
volume 158 ml, LV mass 98 g) and a male elite athlete (B: Body surface area 
2.37 m2, LV end-diastolic volume 317 ml , LV mass 345 g) 
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Table 5. 2: Left and right ventricular volume parameters of elite athletes and 
sedentary controls. 
 Male Female P value 
 SC (n=21) 
Athletes 
(n=23) 
Training
effect 
(%) 
SC 
(n=17) 
Athletes
(n=20) 
Training
effect 
(%) 
Training Sex Interaction 
LV 
ejection 
fraction 
(%) 
67±6 70±6 4 68±7 68±6 0 0.54 0.71 0.32 
LV end-
diastolic 
volume 
index 
(ml/m2) 
89±10 108±10 21 80±10 94±9 18 <0.001 <0.001 0.27 
LV end-
systolic 
volume 
index 
(ml/m2) 
29±7 33±8 14 25±5 31±7 24 0.005 0.054 0.662 
LV stroke 
volume 
index 
(ml/m2) 
60±7 75±9 25 54±9 64±7 19 <0.001 <0.001 0.09 
LV mass 
index 
(g/m2) 
66±9 94±20 42 52±9 70±9 35 <0.001 <0.001 0.09 
          
RV 
ejection 
fraction 
(%) 
58±6 59±7 2 60±5 58±5 -3 0.69 0.54 0.09 
RV end-
diastolic 
volume 
index 
(ml/m2) 
103±13 119±16 16 88±12 106±15 20 <0.001 <0.001 0.78 
RV end-
systolic 
volume 
index 
(ml/m2) 
44±9 48±7 9 35±6 45±9 29 <0.001 0.001 0.10 
RV stroke 
volume 
index 
(ml/m2) 
59±9 71±14 20 53±9 61±9 15 <0.001 0.002 0.40 
RV mass 
index 
(g/m2) 
23±5 28±3 22 21±3 25±3 19 <0.001 0.013 0.66 
SC = sedentary control;  
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The ratios between the LV and RV volumes, masses and ejection 
fractions (Table 5.3) can be used to assess whether LV and RV dilatation and 
hypertrophy are balanced when compared to sedentary controls (Scharhag et 
al., 2002). Both male and female athletes show balanced cardiac dilatation 
(LV/RV ratios for end-diastolic volume, end-systolic and stroke volume index). 
The LV/RV ratio for mass index was significantly increased in athletes 
compared to controls (p for training = 0.006) and in males compared to female 
subjects (p for sex <0.001), but there was no sex-specific difference for the 
changes observed to due exercise training (p for interaction =0.35). 
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Table 5.3: Left-to right ventricular volume parameters of elite athletes and 
sedentary controls. 
 
 Male Female P value 
 SC (n=21) 
Athletes 
(n=23) 
Training
effect 
(%) 
SC 
(n=17) 
Athletes
(n=20) 
Training
effect 
(%) 
Training Sex Inter-action 
LV/RV 
ejection 
fraction 
(%) 
1.2±0.1 1.2±0.2 0 1.1±0.1 1.2±0.1 9 0.27 0.26 0.51 
LV/RV 
end-
diastolic 
volume 
index 
(ml/m2) 
0.9±0.1 0.9±0.1 0 0.9±0.1 0.9±0.1 0 0.30 0.61 0.11 
LV/RV 
end-
systolic 
volume 
index 
(ml/m2) 
0.7±0.1 0.7±0.2 0 0.7±0.2 0.7±0.1 0 0.74 0.27 0.26 
LV/RV 
stroke 
volume 
index 
(ml/m2) 
1.0±0.1 1.1±0.2 10 1.0±0.1 1.1±0.1 10 0.13 0.53 0.50 
LV/RV 
mass 
index 
(g/m2) 
3.0±0.5 3.5±0.7 17 2.5±0.5 2.8±0.5 12 0.006 <0.001 0.35 
SC = sedentary controls; 
Systolic and diastolic myocardial contraction patterns 
Athletes had similar systolic and diastolic contraction patterns when 
compared to sedentary controls (p for training >0.05 for 7 of the 8 systolic and 
diastolic parameters), with the exception of the prolonged time to peak 
systolic longitudinal velocity in athletes (p for training =0.003), and the 
shortened time to peak diastolic longitudinal strain-rate (p for training =0.03). 
Male and female subjects showed similar systolic and diastolic relaxation 
patterns (p for sex >0.05 for all diastolic and for 6 of 8 systolic parameters). 
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Higher peak systolic radial velocities and prolonged time to peak systolic 
longitudinal strain-rate were observed in male compared to female subjects (p 
for sex <0.001 and 0.04, respectively). No sex-specific differences of training 
effect on systolic and diastolic myocardial contraction patterns were observed 
(all p for interaction >0.05, Table 5.4). 
  
Table 5.4: Mean± SD myocardial velocities at mid-ventricular level, myocardial torsion-rate and longitudinal strain-rate in elite 
athletes and sedentary controls. 
 
 Male   Female   P value 
 Sedentary (n=21) 
Athletes 
(n=23) 
Training 
effect 
(%) 
Sedentary 
(n=17) 
Athletes 
(n=20) 
Training 
effect  
(%) 
Train-
ing Sex 
Inter-
action 
Peak systolic radial velocity [cm.s-1] 3.64±0.58 3.74±0.91 -3 3.09±0.64 3.09±0.51 0 0.73 <0.001 0.75 
Peak systolic longitudinal velocity [cm.s-1] -4.74±1.97 -4.64±2.49 2 -3.91±-1.51 -4.28±2.39 -9 0.79 0.27 0.66 
Peak systolic torsion-rate [deg. s-1. cm-1] 15.07±4.86 15.50±3.41 -3 16.02±4.36 13.01±3.30 23 0.17 0.41 0.07 
Peak systolic longitudinal strain-rate [s-1] -1.12±0.33 -1.03±0.39 9 -1.09±0.27 -0.89±0.28 22 0.09 0.29 0.49 
Peak diastolic radial velocity [cm.s-1] -4.21±0.83 -4.55±0.88 -8 -3.91±1.56 -4.42±1.01 -13 0.09 0.39 0.74 
Peak diastolic longitudinal velocity [cm.s-1] 8.10±2.00 9.30±1.71 -15 8.81±1.70 8.96±1.85 -2 0.13 0.68 0.24 
Peak diastolic torsion-rate [deg. s-1. cm-1] -11.61±4.97 -14.52±3.90 -25 -11.87±4.18 -12.70±4.61 -7 0.07 0.45 0.31 
Peak diastolic longitudinal strain-rate [s-1] 1.52±0.62 1.39±0.46 9 1.73±0.65 1.44±0.69 20 0.16 0.39 0.61 
          
Time to peak systolic radial velocity [%ES] 39±7 39±7 0 41±12 42±7 -2 0.72 0.19 0.64 
Time to peak systolic longitudinal velocity [%ES] 16±27 39±46 -144 13±20 47±45 -262 0.003 0.73 0.56 
Time to peak systolic torsion-rate [%ES] 69±43 53±24 30 69±36 54±23 28 0.96 0.93 0.053 
Time to peak systolic longitudinal strain-rate [%ES] 45±15 50±25 -11 55±13 61±24 -11 0.27 0.04 0.86 
Time to peak diastolic radial velocity [%ED] 18±4 19±6 -6 20±10 19±4 5 0.97 0.60 0.58 
Time to peak diastolic longitudinal velocity [%ED] 19±7 20±5 -5 19±6 18±14 6 0.87 0.67 0.71 
Time to peak diastolic torsion-rate [%ED] 8±6 7±10 14 13±12 9±4 44 0.23 0.10 0.58 
Time to peak diastolic longitudinal strain-rate 
[%ED] 19±7 18±7 -6 22±7 15±9 -47 0.03 0.98 0.21 
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5.4 Discussion 
Our principal finding is that young adult elite athletes show no sex-
specific adaptive structural and functional changes to chronic physiological 
cardiac remodelling. This is in contrast to findings observed in models of 
chronic pathological remodelling thought to be modulated by the sex-specific 
hormonal milieu (Marsh et al., 1998; Xin et al., 2002; Cavasin et al., 2003; 
Nahrendorf et al., 2003; Skavdahl et al., 2005). This study, therefore, provides 
further evidence for the benign nature of the hypertrophy associated with 
athlete’s heart. 
Sex-specific structural cardiac changes to exercise training 
Our finding that athletes, mainly engaged in rowing, swimming and 
triathlon, show an unbalanced left and right ventricular hypertrophy, favouring 
the LV, contrasts with a report by Scharhag and colleagues in male 
endurance athletes (Scharhag et al., 2002). This discrepancy might reflect 
differential effects to exercise type or severity as well as duration of training. 
The LV mass (and index) increase in male athletes was comparable for both 
studies (42% in our study vs. 36%), whereas the RV mass (and index) 
increased only by 22% in our study as compared to 37% in theirs. We report 
LV to RV volume and mass ratios for the first time in female athletes, 
demonstrating absence of sex-specific differences to exercise training. 
Our results show balanced left and right ventricular dilatation in both 
male and female athletes, as determined by the LV to RV ratio of end-
diastolic, end-systolic and stroke volume. These findings confirm previous 
observations for male athletes and extend them to female athletes (Scharhag 
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et al., 2002). Our findings suggest that there is no sex-specific difference of 
balanced cardiac dilatation due to chronic physiological dilatation.  
The absence of sex-specific structural changes in chronic physiological 
cardiac remodelling is in contrast with observations made in models of chronic 
pathological remodelling. These sex-specific changes in pathological 
remodelling have been attributed to estrogens preventing and androgens 
facilitating cardiac hypertrophy (Marsh et al., 1998; Xin et al., 2002; Cavasin 
et al., 2003; Nahrendorf et al., 2003; Skavdahl et al., 2005). However, recent 
molecular studies have indicated a fundamental difference in calcium-
sensitive signalling pathways leading to pathological (including calcineurin-
NFAT) and physiological (via the activation of Akt through a phosphoinositide 
3-kinase pathway) hypertrophy (McMullen et al., 2003). Therefore, the most 
likely explanation for the lack of sex-specific adaptive cardiac structural 
changes due to exercise training is the underlying difference in the 
pathophysiological mechanisms leading to cardiac hypertrophy and dilatation. 
In our study we have not documented androgen and oestrogen levels in 
sedentary controls and athletes. Therefore, a change of the hormonal balance 
due to extensive training in male and female athletes contributing to the lack 
of sex-specific cardiac changes cannot be ruled out (Steinacker et al., 1993; 
Uusitalo et al., 1998).  
Sex-specific changes of cardiac contraction and relaxation to exercise training 
Our results indicate essentially normal contraction and relaxation in 
highly-trained athletes. Furthermore, there were no sex-specific changes to 
exercise training on these systolic and diastolic parameters. While our and 
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previous studies agree on normal systolic function (Pluim et al., 2000; Whyte 
et al., 2004a), previous studies have been conflicting with regards to diastolic 
function in athletes. Doppler-echocardiography and tissue Doppler imaging 
studies have shown either normal (Varani et al., 1989; Lewis et al., 1992; Lai 
et al., 1998; Jungblut et al., 2000; Hoogsteen et al., 2004; Whyte et al., 
2004a; Whyte et al., 2004b) or augmented diastolic function (Douglas and 
O'Toole, 1992; Palazzuoli et al., 2001; D'Andrea et al., 2002; Hoogsteen et 
al., 2003). A disadvantage of some of the previous studies is the lack of age- 
and sex-matched groups of sedentary controls (D'Andrea et al., 2002; 
Hoogsteen et al., 2003; Hoogsteen et al., 2004).  
Human and experimental studies indicate that estrogens can positively 
modulate myocardial function. A number of studies have shown that healthy 
pre-menopausal women have higher ejection fractions compared to healthy 
age-matched men (Buonanno et al., 1982; Hayward et al., 2000) or to post-
menopausal women (Pines et al., 1992). Similarly, papillary muscles from 
female rats have higher rates of shortening than male (Capasso et al., 1983) 
and than gonadectomised female rats (Schaible and Scheuer, 1984). The 
absence of sex-specific adaptive functional changes in our study suggests 
that this oestrogen effect may be important for baseline cardiovascular 
characteristics, but not for adaptive functional cardiac changes due to 
exercise training. 
In conclusion, young adult elite athletes do not show sex-specific 
adaptive structural and functional changes to exercise training. Our data give 
further evidence of the benign nature of athlete’s heart. 
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CHAPTER 6: Differentiation of athlete’s heart from 
pathological forms of cardiac hypertrophy by means of 
geometric indices derived from cardiovascular magnetic 
resonance 
6.1 Introduction 
Determining the underlying aetiology of left ventricular (LV) 
hypertrophy in patients is often a challenging clinical problem. Various 
pathological forms of LV hypertrophy, such as due to hypertrophic 
cardiomyopathy (HCM), hypertensive heart disease or aortic stenosis, and 
physiological forms of LV hypertrophy, such as in athlete’s hearts, can 
present with overlapping cardiac hypertrophy phenotypes as determined by 
2D-echocardiography or ECG. However, in clinical practice, the distinction 
between physiological hypertrophy occurring in athletes and pathological 
hypertrophy is critical because HCM accounts for about one-third of exercise-
related sudden deaths in young competitive athletes (Maron et al., 1980; 
Maron et al., 1986; Burke et al., 1991; Corrado et al., 1998) . Furthermore, in 
athletes with hypertension, the relative contributions of increased blood 
pressure and physical training to the degree of LV hypertrophy detected need 
to be clarified, and this has implications as to the recommendation of 
treatment with antihypertensive agents in this situation. 
Various pathophysiological mechanisms are responsible for the 
development of LV hypertrophy. In aortic stenosis and hypertensive heart 
disease, the resulting chronic LV pressure overload leads to compensatory 
concentric hypertrophy. Athlete’s heart is thought to represent a physiological 
adaptation either to pressure overload (strength-trained athletes) or volume 
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overload (endurance-trained athletes), leading to concentric or eccentric LV 
hypertrophy, respectively. Most sport disciplines yield a combination of both 
mechanisms (Morganroth et al., 1975; Pelliccia et al., 1991; Maron et al., 
1995; Pelliccia et al., 1999; Pluim et al., 2000; Maron, 2003; Whyte et al., 
2004b). The precise pathophysiological mechanisms underlying LV 
hypertrophy in patients with HCM remain controversial (Ashrafian et al., 
2003): However, in contrast to pressure or volume overload LV hypertrophy, 
the hypertrophic stimulus in HCM is intrinsic to the myocardium. 
We therefore hypothesized that these differences in pathophysiology 
lead to subtle differences in the cardiac hypertrophy phenotype, which can be 
detected by a highly sensitive imaging technique (Grothues et al., 2002). 
Cardiac magnetic resonance (CMR) provides high image quality and is 
intrinsically three-dimensional, not relying on geometric assumptions, and is, 
thus, the currently accepted gold standard method for the measurement of 
cardiac volumes and mass (Bellenger et al., 2000).  
Therefore, we employed CMR imaging to test whether CMR-derived 
LV volume parameters and geometric indices accurately predict the 
underlying etiology of LV hypertrophy. This hypothesis was tested in groups 
of patients with HCM, hypertension, and aortic stenosis, and in athletes. 
6.2 Methods 
Study participants 
A total of 120 subjects were studied. Patients with LV hypertrophy and 
a preserved LV ejection fraction (greater than 50%) were enrolled (n=102). 
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Each participant with LV hypertrophy fell into one of the following groups: 
Competitive athletes (n=25; 25±4 years), hypertrophic cardiomyopathy (n=35; 
43±17 years), hypertensive heart disease (n=18; 52±12 years), and aortic 
stenosis (n=24; 67±15 years). 18 healthy volunteers served as a reference 
group (41±13 years). 
Athletes were recruited solely on the basis of participation in high-level 
competitive sports, which were principally rowing, swimming, running and 
cycling for at least the previous 18 months, with an average of 19.2±6.8 hours 
training per week for the last 8.5± 4.9 years. None of the athletes were 
hypertensive or had any cardiovascular disease or risk factors. HCM patients 
were recruited from the University of Oxford Cardiomyopathy and Heart 
Failure Clinic at the John Radcliffe Hospital, and the clinical diagnosis of HCM 
was based on family history, standard electrocardiographic and 
echocardiographic criteria (end-diastolic wall thickness of greater 13 mm) in 
the absence of secondary causes for left ventricular hypertrophy. None of the 
HCM patients had hypertension. Hypertensive patients were enrolled if they 
showed an end-diastolic wall thickness of greater 13 mm on 
echocardiography. Additionally, a history of longstanding hypertension, 
documentation of hypertension on 24 hour ambulatory blood pressure 
readings (>140/90 mmHg) and at least one antihypertensive medication were 
required. The average number of antihypertensive drugs was 3.3±1.5. In 
patients with aortic stenosis, the peak instantaneous aortic valve gradient was 
71±27 mmHg. In addition, all aortic stenosis patients showed 
echocardiographic evidence of LV hypertrophy (end-diastolic wall thickness of 
greater 13 mm). Although aortic stenosis is clinically easily diagnosed by 
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examination and echocardiography, this group was included in our study to 
compare the LV morphologic phenotype arising from this form of pressure 
overload with the phenotypes caused by other forms of pathological and 
physiological LV hypertrophy. All groups other than athletes did not perform 
physical training at a level or duration that would be expected to cause LV 
hypertrophy. Baseline characteristics of subjects are also given in Table 6.1. 
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Table 6.1: Baseline characteristics and left ventricular volume results 
  Groups with LVH  
Diagnosis 
(∑ n=120) 
Healthy Volunteers 
(n=18) 
AH 
(n=25) 
HCM 
(n=35) 
HHD 
(n=18) 
AS 
(n=24) 
p-value 
Age 
[years] 
41 ± 13 
(26-68) 
25 ± 4* 
(20-35) 
43 ± 17 
(15-78) 
52 ± 12 
(20-71) 
67 ± 15* 
(33-89) 
P<0.01 
Gender 6m/12f 12m/13f 26m/9f 15m/3f 15m/9f n.s.§ 
BSA 
[m-2] 
1.75 ± 0.19 
(1.28-2.07)  
1.87 ± 0.15 
(1.61-2.28) 
1.98 ± 0.29 
(1.14-2.48) 
2.07 ± 0.25 
(1.69-2.47) 
1.94 ± 0.23 
(1.51-2.40) 
n.s. 
Body 
weight 
[kg] 
66 ± 12 
(38-88) 
70 ± 10† 
(55-94) 
82 ± 18 
(36-119) 
88 ± 19† 
(60-120) 
80 ± 15 
(55-117) 
P<0.01 
Heart rate 
[bpm] 
67 ± 16 
(50-112) 
61 ± 9 
(46-78) 
58 ± 11 
(44-91) 
65  ± 12 
(49-100) 
64 ± 9 
(49-80) 
n.s. 
Mean BP 
[mmHg] 
98 ± 7 
(92-116) 
82 ± 8‡ 
(67-106) 
92 ± 10‡ 
(65-113) 
112 ± 20* 
(90-170) 
88 ± 14 
(73-118) 
P<0.01 
LV mass 
index 
[g/ m-2] 
55.6 ± 9.9 
(40.3-78.9) 
75.8 ± 15.5 
(55.0-125.7) 
85.0 ± 27.3 
(48.1-161.3) 
75.6 ± 10.1 
(51.4-93.6) 
93.7 ± 40.1 
(46.9-218.2) 
n.s. 
LVEF 
[%] 
72 ± 6 
(60-80) 
68 ± 6* 
(58-88) 
76 ± 6 
(61-86) 
76 ± 6 
(67-86) 
76 ± 10 
(54-90) 
P<0.01 
LVEDVI 
[ml/ m-2] 
79 ± 12 
(63-101) 
99 ± 11* 
(80-115) 
77 ± 14 
(47-111) 
76 ± 12 
(58-94) 
76 ± 25 
(44-134) 
P<0.01 
LVESVI 
[ml/ m-2] 
23 ± 6 
(14-34) 
31 ± 7* 
(13-45) 
19 ± 7 
(9-41) 
19 ± 6 
(11-29) 
20 ± 13 
(6-56) 
P<0.01 
LVSVI 
[ml/ m-2] 
56 ± 9 
(42-72) 
68 ± 10* 
(51-96) 
58 ± 10 
(33-76) 
58 ± 9 
(44-73) 
57 ± 16 
(34-98) 
P<0.01 
 
HCM=hypertrophic cardiomyopathy; HHD=hypertensive heart disease; AS=aortic stenosis; 
AH=athlete’s heart; BSA=body surface area; bpm=beats per minute; LV= left ventricular; 
LVEF=LV ejection fraction; LVEDVI= LV end-diastolic volume index; LVESVI= LV end-
systolic volume index; LVSVI = LV stroke volume index. One-way ANOVA with Bonferroni 
post-hoc corrections was applied for the four groups of left ventricular hypertrophy unless 
stated otherwise. Results of healthy volunteers’ are presented for reference purposes. As the 
aim of this study was the identification of differences in various forms of LV hypertrophy, only 
these groups were used for statistical analysis. * p<0.01 versus all other cardiac hypertrophy 
groups;† p<0.01 between the groups with this symbol; ‡ p<0.05 between the groups with this 
symbol; § The Kruskal-Wallis-test for qualitative parameters was applied. 
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MR imaging 
Steady state free precession cine images were acquired as described 
in chapter 2. 
Data Analysis 
Cine images were analysed as described in chapter 2, with an 
experienced analyser blinded to the diagnosis. For each set of Cine studies, 
standard LV volume parameters were generated: LV ejection fraction (LVEF), 
LV mass index, LV end-diastolic (LVEDVI), end-systolic (LVESVI) and stroke 
volume index (LVSVI). Geometric indices were computed to analyse the 
three-dimensional distribution of cardiac hypertrophy assessing all myocardial 
segments (Cerqueira et al., 2002). In each of the three diastolic long axis 
views and in a basal short axis slice at a level between the LV outflow tract 
and the papillary muscles (Figure 6.1) the segment with the thickest and the 
thinnest myocardial diameter was chosen for measurement. Only the maximal 
(i.e. thickest) and the minimal (i.e. thinnest) end-diastolic wall thickness were 
then used for analysis. These values were then used to calculate maximal 
end-diastolic wall thickness (“diastolic wall thickness”) and end-diastolic 
maximal-to-minimal wall thickness ratios (“wall thickness ratio”). End-diastolic 
maximal wall thickness-to-LVEDVI (“diastolic wall-to-volume ratio”; a measure 
of wall thickness in relation to heart size) and end-systolic minimal wall 
thickness-to-LVESVI (“systolic wall-to-volume ratio”; a measure of contractility 
in the least hypertrophied region of the heart) were also calculated. 
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Figure 6.1: Planning image positions to allow three-dimension analysis of 
wall thickness distribution. By rotating imaging planes by 60˚ around an 
imaginary axis at the centre of the left ventricular cavity in pilot short axis 
views (SA), the left ventricular outflow tract (LVOT) can be imaged, and 
horizontal (HLA) and vertical long axis (VLA) views can be generated. The 
basal short axis slice shows 6 segments according to the AHA convention. 
Statistical Analysis 
Results of healthy volunteers are presented for reference purposes. As 
the aim of this study was the identification of differences amongst various 
forms of LV hypertrophy, only these groups were used for statistical analysis. 
All data are presented as mean±SD (range) unless stated otherwise. Nominal 
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data were tested for differences between multiple groups using the Kruskal-
Wallis test. Continuous data were analysed using ANOVA with post-hoc 
Bonferroni analysis to establish differences between the individual groups. A 
p-value of <0.05 was considered statistically significant. Multiple logistic 
regression analysis was performed to identify the values of LV volume and 
geometric indices to allow correct diagnosis of LV hypertrophy. Receiver 
operating characteristics were used to generate cut-off values for optimised 
sensitivity and specificity to distinguish athlete’s heart from pathological 
cardiac hypertrophy. All computations were done with SPSS 11.0 (SPSS Inc., 
Chicago, US). 
6.3 Results 
Characteristics of subject and patient groups 
All groups with LV hypertrophy had similar LV mass indices (p>0.05 for 
all four LV hypertrophy groups), which were, on average, at least 35%higher 
than those obtained in healthy volunteers (p<0.05 for combined LV 
hypertrophy groups vs. healthy volunteers; t-test for unpaired variables, Table 
6.1). The four LV hypertrophy groups were also similar with regard to gender, 
heart rate and body surface area (p>0.05 for all, Table 6.1). As expected, 
mean blood pressure was higher in hypertensive patients (p<0.01 vs. all 
groups). Hypertensive patients had a higher body weight compared to 
athletes (p<0.01). As is typical for athlete’s heart, LV end-diastolic, end-
systolic and stroke volume indices were all higher in the athletes group 
(p<0.01 for all three parameters vs. all groups). All ECG findings were normal 
in athletes. 
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Geometric indices 
Diastolic wall thickness was significantly lower in athletes (Figure 6.2, 
Table 6.2) as compared to the other three groups with pathological cardiac 
hypertrophy (p<0.01). 10/25 (40%) athletes showed a diastolic wall thickness 
greater than 13 mm and 1/25 (4%) a wall thickness of greater than 16 mm. 
HCM patients showed the largest diastolic wall thickness, which was also 
significantly higher than wall thickness in hypertensive heart disease (p<0.01, 
Table 6.2). However, only 7 of 35 (20%) HCM patients presented with a wall 
thickness above the highest values of the other LV hypertrophy groups. Wall 
thickness ratio was highest for HCM (p<0.01 vs. AH, p<0.05 vs. AS), lowest 
for athletes and intermediate for hypertensive patients (n.s. vs. all other 
groups) and aortic stenosis. 2 of the 35 patients (6%) with HCM showed 
symmetric LV hypertrophy with a wall thickness ratio of less than 1.3. 
Diastolic wall-to-volume ratio was lowest in athletes (p<0.01 compared to all 
other groups) and was highest in HCM patients (Table 6.2). Athletes also had 
the lowest systolic wall-to-volume ratio (p<0.01 compared to all other groups), 
while aortic stenosis patients showed the highest ratio (p<0.05 compared to 
HCM, p<0.01 compared to athletes).
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Figure 6.2: End-diastolic steady-state free precession cine images in a 
patient with hypertrophic cardiomyopathy (A-D) and in a competitive athlete 
with athlete’s heart (E-H). A/E: horizontal long axis, B/F: vertical long axis, 
C/G: left ventricular outflow tract and D/H: basal short axis view. In each of 
the three diastolic long axis views and in a basal short axis slice at a level 
between the LV outflow tract and the papillary muscles (Figure 1) the 
segment with the thickest and the thinnest myocardial diameter was chosen 
for measurement (white lines). Only the maximal (i.e. thickest) and the 
minimal (i.e. thinnest) end-diastolic wall thickness were then used for 
analysis. These values were then used to calculate maximal end-diastolic wall 
thickness (“diastolic wall thickness”) and end-diastolic maximal-to-minimal 
wall thickness ratios (“wall thickness ratio”). 
 
  
Table 6.2: Geometric indices 
  Groups with LVH  
Diagnosis 
(∑ n=120) 
Healthy Volunteers 
(n=18) 
AH  
(n=25) 
HCM 
(n=35) 
HHD 
(n=18) 
AS 
(n=24) 
p-value 
Diastolic wall 
thickness [mm] 
11.1 ± 1.1 
(9.3-12.6) 
12.8 ± 1.8* 
(9.7-16.6) 
21.5 ± 5.9† 
(14.3-36.5) 
17.0 ± 2.6† 
(13.2-22.4) 
19.4 ± 3.8 
(13.1-26.6) 
P<0.01 
Wall thickness ratio 
[a.u.] 
1.43 ± .22 
(1.11-2.03) 
1.42 ± 0.17† 
(1.09-1.87) 
2.25 ± 1.07†,‡ 
(1.01-7.45) 
1.77 ± 0.41 
(1.27-2.77) 
1.76 ± 0.35‡ 
(1.28-2.70) 
P<0.01 
Diastolic wall-to-
volume ratio 
[mm*m2/ml] 
0.14 ± 0.03 
(0.1-0.2) 
0.13 ± 0.02* 
(0.1-0.2) 
0.29 ± 0.10 
(0.2-0.5) 
0.23 ± 0.07 
(0.2-0.4) 
0.28 ± 0.10 
(0.1-0.6) 
P<0.01 
Systolic wall-to-
volume ratio 
[mm*m2/ml] 
0.56 ± 0.23 
(0.3-1.0) 
0.42 ± 0.15* 
(0.2-1.0) 
0.86 ± 0.32‡ 
(0.4-1.9) 
0.92 ± 0.36 
(0.4-1.7) 
1.22 ± 0.82‡ 
(0.3-3.3) 
P<0.01 
HCM=hypertrophic cardiomyopathy; HHD=hypertensive heart disease; AS=aortic stenosis; AH=athlete’s heart; a.u.=arbitrary units; Diastolic wall thickness = 
maximal end-diastolic wall thickness; wall thickness ratio=ratio of maximal-to-minimal wall thickness; diastolic wall-to-volume ratio=maximal end-diastolic wall 
thickness-to-left ventricular end-diastolic volume index; systolic wall-to-volume ratio=minimal end-systolic wall thickness-to-left ventricular end-systolic volume 
index. The data are presented as mean ± standard deviation (range). One-way ANOVA with Bonferroni post-hoc corrections was applied for the four groups 
of left ventricular hypertrophy. Results of healthy volunteers’ are presented for reference purposes. As the aim of this study was the identification of 
differences in various forms of LV hypertrophy, only these groups were used for statistical analysis.* p<0.01 versus all other cardiac hypertrophy groups; † 
p<0.01 between the groups with this symbol; ‡ p<0.05 between the groups with this symbol 
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Diagnostic accuracy of geometric indices to differentiate the underlying 
aetiology of cardiac hypertrophy 
Receiver operating characteristics identified the diastolic wall-to-
volume ratio as the best parameter (i.e. the highest area under the curve of 
0.993) to differentiate athlete’s heart from all other pathological hypertrophy 
forms. A cut-off value for diastolic wall-to-volume ratio of less than 0.15 
mm*m2*ml-1 discriminated between physiological and pathological LV 
hypertrophy with a sensitivity of 80%, a specificity of 99%, a positive 
predictive value of 95% and a negative predictive value of 94% (Table 6.3, 
Figure 6.3).
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Figure 6.3: Receiver operating characteristics of the diastolic wall-to-volume 
ratio to distinguish athlete’s heart from pathological left ventricular 
hypertrophy. The area under the curve is 0.993, and for a cut-off value of 0.15 
mm*m2*ml-1 this parameter provides a sensitivity and specificity of 80% and 
99%, respectively. The positive and negative predictive values were 95% and 
94%, respectively.
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Table 6.3: Diagnostic accuracy for differentiation of physiological from 
pathological LV hypertrophy 
 
 Sens Spec pos pred neg pred AUC 
Diastolic wall thickness 
<13 mm 
40% 100% 100% 84% 0.955 
Wall thickness ratio<1.3 28% 95% 64% 95% 0.862 
Diastolic wall-to-volume ratio 
<0.15 mm*m2/ml 
80% 99% 95% 94% 0.993 
Systolic wall-to-volume ratio 
<0.26 mm*m2/ml 
4% 100% 100% 76% 0.926 
Sens=sensitivity; spec=specificity; pos pred=positive predictive value; 
neg pred=negative predictive value; AUC=area under the curve for analysis based on 
receiver operating curves. 
To analyse the diagnostic accuracy of CMR in differentiating between 
all four forms of cardiac hypertrophy studied, MR parameters derived from LV 
volume studies (LV mass index, LVEF, LVEDVI, LVESVI, LVSVI) and 
geometric indices (diastolic wall thickness, wall thickness ratio, diastolic wall-
to-volume ratio and systolic wall-to-volume ratio) were subjected to multiple 
logistic regression analysis. The number and percentage of patients correctly 
classified with these parameters were computed (Table 6.4). Athlete’s hearts 
were correctly classified in 100% of cases, HCM in 80%, aortic stenosis 
patients in 54% and hypertensive heart disease in 22%. Importantly, no 
athlete was misclassified as having HCM in spite of a maximal wall thickness 
of 16 mm and no patient with HCM as athlete’s heart. Hypertensive heart 
disease was the most commonly misclassified condition, and could be 
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mistaken for any form of pathological cardiac hypertrophy, but, importantly, 
not for athlete’s heart. Aortic stenosis was sometimes misclassified as 
hypertensive heart disease or HCM, but, again, never as athlete’s heart. 
Thus, no single LV geometric index could identify athletes with 100% 
diagnostic accuracy, but multiple logistic regression analysis, taking into 
account all measured parameters, was 100% correct in distinguishing 
athlete’s heart from all other forms of LV hypertrophy. 
Table 6.4: Classification table showing the prediction of diagnosis based 
on a multiple logistic regression analysis including left ventricular volume 
parameters (LVEF, LVEDVI, LVESVI, LVSVI, LV mass index) and geometric 
indices (diastolic wall thickness, wall thickness ratio, diastolic wall-to-volume 
ratio, systolic wall-to-volume ratio) 
Real 
Diagnosis 
Predicted Diagnosis 
 HCM HHD AS AH Percent 
correct 
HCM (n=35) 28 (80%) 3 (9%) 4 (11%) 0 (0%) 80% 
HHD (n=18) 10 (56%) 4 (22%) 4 (22%) 0 (0%) 22% 
AS (n=24) 8 (33%) 3 (13%) 13 (54%) 0 (0%) 54% 
AH (n=25) 0 (0%) 0 (0%) 0 (0%) 25 (100%) 100% 
 
6.4 Discussion 
Our principal finding is that physiological LV hypertrophy can reliably 
be distinguished from pathological LV hypertrophy, such as in HCM, 
hypertensive heart disease and aortic stenosis, based on CMR-derived LV 
geometric indices. In contrast, these forms of pathological LV hypertrophy 
present with an overlapping cardiac hypertrophy phenotype. 
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Identification of Athlete’s heart by CMR indices 
Distinction of pathological and physiological LV hypertrophy remains a 
frequent clinical dilemma. In current clinical practice, one strategy of 
distinguishing athlete’s heart from pathological LV hypertrophy is to document 
the deconditioning effect after training cessation for several months (Martin et 
al., 1986; Maron et al., 1993; Pelliccia et al., 2002). However, this is often not 
acceptable to athletes. Metabolic exercise testing has been shown to facilitate 
the differentiation between athlete’s hearts and HCM (Sharma et al., 2000). 
Our study suggests a novel approach to distinguish athlete’s heart from 
various forms of pathological LV hypertrophy by means of three-dimensional 
CMR-derived LV volume and geometric indices, obviating the need for ‘de-
training’ to make this distinction.  
Importantly, in our study, no athlete was misdiagnosed as having HCM 
in spite of a wall thickness of greater 16 mm, and no patient with HCM was 
diagnosed as having physiological LV hypertrophy. This is of clinical 
importance, as labelling athletes with a diagnosis of HCM would disqualify 
them from competitive exercise in addition to the psychological and 
socioeconomic impact of this diagnosis. On the other hand, missing HCM in 
athletes would expose them to a high risk of sudden cardiac death, as HCM is 
the most common cause of sudden death in the population under 35 years of 
age (Maron et al., 1980; Maron et al., 1986; Burke et al., 1991).  
Our findings also confirm that cardiac morphologic changes in athletes 
are different from those induced by pressure overload LV hypertrophy. 
Athlete’s hearts are characterised by larger LV volumes, smaller ejection 
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fractions, and less pronounced wall thickness, despite a similar LV mass 
index. The differentiation of athlete’s heart from hypertensive heart disease is 
clinically relevant, and athletes with additional LV hypertrophy secondary to 
hypertension should be treated vigorously with antihypertensive medication. 
This is supported by a recent meta-analysis (Verdecchia et al., 2003) showing 
that regression of LV hypertrophy by antihypertensive treatment is associated 
with a marked reduction in risk for subsequent cardiovascular disease. 
Our findings are in keeping with one previous study using 
echocardiography, which suggested that geometric indices are useful in 
distinguishing athlete’s heart from hypertrophic cardiomyopathy (Devlin and 
Ostman-Smith, 2000). However, this study did not include other forms of 
pathological LV hypertrophy. In principle, CMR can detect changes of LV 
parameters with a much smaller sample size than echocardiography (for 
equivalent statistical power) due to the high inter-study reproducibility and the 
observer-independence of the method. As in our study, the measurements by 
Grothues and colleagues were based on manual detection of endo-and 
epicardial contours with coeffients of variability for inter-study reproducibility of 
3.6% for CMR and 13.5% for echocardiography in LV hypertrophy patients 
(Grothues et al., 2002). Thus, to detect a 10 g difference in LV mass index, 
CMR allows a reduction of the sample size by 90%. 
Pathological forms of LV hypertrophy 
The differential diagnosis of patients with pathological cardiac 
hypertrophy remains difficult, even with a high-resolution, three-dimensional 
technique, such as CMR. The finding of similar patterns of cardiac 
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hypertrophy amongst different pathological hypertrophy etiologies is of clinical 
relevance. The ACC/ESC Expert consensus document (Maron et al., 2003) 
states that in HCM, LV wall thickening is found in the absence of another 
cardiac or systemic disease capable of producing the magnitude of 
hypertrophy evident. However, coexistence of pathologies, for example of 
hypertension and HCM, is not unusual. In addition, genotype-phenotype 
correlations have shown that virtually any LV wall thickness is compatible with 
HCM (Watkins et al., 1995). In our cohort, only 20% of HCM patients 
presented with a wall thickness above the maximal values seen in 
hypertension and aortic stenosis. Consequently, in the presence of coexisting 
pathologies that cause LV hypertrophy, a majority of the HCM patients in our 
study could not have been classified as affected by the ACC/ESC criteria. 
Genetic analysis to identify HCM mutations may be particularly valuable in 
patients with multiple potential causes of LV hypertrophy, such as in HCM 
family members with hypertension. 
One possible explanation for the similarity of the cardiac muscle 
phenotypes in pathological hypertrophy may be a common intracellular 
signalling pathway mediating myocardial growth. A rise in intracellular calcium 
elicited by mechanical stretch (in aortic stenosis and hypertension) or altered 
bioenergetics (in HCM) (Frey et al., 2000; Ashrafian et al., 2003; Frey and 
Olson, 2003; Wilkins et al., 2004) has been identified as the key step leading 
to the activation of calcium-sensitive signalling pathways (including 
calcineurin-NFAT ) and myocardial growth. Conversely, recent findings have 
indicated that physiological hypertrophy may result from the activation of Akt 
through a phosphoinositide 3-kinase (PI3K) pathway (McMullen et al., 2003). 
Chapter 6 119 D.Phil. thesis: S.E. Petersen 
 
Hypertrophy and cardiac asymmetry 
Asymmetric LV hypertrophy is considered the hallmark of HCM, and 
traditionally, the wall thickness ratio has been widely used for the diagnosis of 
this disease. However, our results indicate that this parameter provides the 
least diagnostic accuracy for the differentiation of LV hypertrophy compared 
to the other geometric indices used. Cardiac muscle asymmetry, thus, is not 
solely associated with HCM. Furthermore, symmetric forms of HCM appear to 
be more common than may be appreciated; 6% of patients with HCM in our 
cohort showed symmetrical LV hypertrophy. For the distinction of 
physiological LV hypertrophy from HCM, this is particularly problematic as 
symmetrical HCM appears to be more common in the athletic HCM sub-
population. Maron and colleagues found that up to 43% of athletes who 
suffered sudden death due to HCM had normal septum to LV wall ratios in the 
heart arrested in systole at autopsy (Maron et al., 1980).  
Cardiac muscle asymmetry also shows a wide and overlapping 
spectrum in both athletes and in pathological cardiac hypertrophy. 
Furthermore, even in the absence of LV hypertrophy, our findings in healthy 
volunteers show a degree of asymmetry in line with previous reports (Kansal 
et al., 1979; Doi et al., 1980). Consequently, asymmetry as determined by 
high-resolution, three-dimensional CMR cannot reliably differentiate HCM 
from pressure overload LV hypertrophy. The pathoanatomical substrate 
underlying the phenomenon of asymmetric hypertrophy, as seen across the 
spectrum of groups studied, maybe denser sympathetic innvervation of the 
interventricular septum compared to the lateral wall (Ostman-Smith, 1981). 
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Limitations 
Our study populations were, inevitably, dissimilar with regards to age 
(athletes were younger, aortic stenosis patients were older) and weight 
(despite a similar body surface area, the hypertensive patients were more 
obese). However, echocardiographically determined geometric indices have 
been shown to be independent of sex and body size (Ostman-Smith and 
Devlin, 2001). Additionally, we normalised all volume parameters to body 
surface area. Furthermore, our results were unchanged when we normalized 
LV parameters to body height instead of surface area (data not shown).  
Athletes were ascertained if they participated in high-level physical 
training and athletic competition so as to be representative of the type of 
patient in whom the differential diagnosis of cardiac hypertrophy presents a 
problem. This selection resulted in similar elevation of mean LV mass index 
as was seen in the pathological hypertrophy groups but not all athletes had a 
diastolic wall thickness of greater than 13 mm. Thus the distribution of 
geometric measurements will be somewhat different in the athletes as wall 
thickness of greater than 13 mm was an inclusion criterion for HCM, 
hypertensive heart disease and aortic stenosis. Probably as a result of our 
very stringent selection, many of our elite athletes (40%) had a wall thickness 
of greater than 13 mm. CMR may tend to yield higher numbers for diastolic 
wall thickness than echocardiography. The inclusion of athletes with both, 
increased and normal wall thickness, but all with increased LV mass indices, 
appears important as HCM patients may be phenotype negative gene 
carriers. 
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While we cannot rule out HCM with absolute certainty in athletes with 
increased wall thickness, none of these athletes had an abnormal ECG, a 
positive family history or cardiovascular symptoms; therefore, a diagnosis of 
HCM is statistically highly unlikely. 
Conclusions 
We propose the use of CMR-derived LV volume and geometric indices 
for clinical practice to distinguish athlete’s hearts from pathological forms LV 
hypertrophy. These indices, however, cannot differentiate HCM and LV 
hypertrophy secondary to systemic hypertension or aortic stenosis. 
Chapter 7 122 D.Phil. thesis: S.E. Petersen 
 
CHAPTER 7: Left ventricular non-compaction: Insights from 
cardiovascular magnetic resonance imaging 
7.1 Introduction 
Left ventricular non-compaction (LVNC) is characterized by the 
presence of an extensive non-compacted myocardial layer lining the cavity of 
the left ventricle, and potentially leads to cardiac failure, thromboembolism, 
and malignant arrhythmias (Ritter et al., 1997; Oechslin et al., 2000). It can be 
associated with neuromuscular disorders (Stollberger et al., 2002), and can 
co-exist with other cardiac malformations (Oechslin et al., 2000). Based on 
echocardiographic studies, its prevalence has been estimated at 0.05% in the 
general population (Ritter et al., 1997), and the finding of a ratio of greater 
than 2.0 between the thickness of the non-compacted and compacted 
myocardial layers in systole is considered diagnostic (Jenni et al., 2001). 
Echocardiography, however, poses inherent problems in assessing the LV 
apex, known to be the most commonly non-compacted area (Moon et al., 
2004). 
As high resolution imaging techniques, such as multi-detector CT, have 
shown the frequent presence of pronounced trabeculae within healthy 
myocardium (Axel, 2004), a similar finding may be expected with 
cardiovascular magnetic resonance (CMR) in both healthy and diseased 
hearts, which is increasingly used in clinical practice. Accordingly, it is 
necessary to establish specific CMR criteria for the diagnosis of pathological 
non-compaction. To this end, we examined healthy volunteers as well as 
patients with potential differential diagnoses for LVNC. Findings from this 
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group were compared with unequivocal LVNC cases in whom the diagnosis 
was supported by other clinical features. 
7.2 Methods 
The study was approved by our institutional ethics committee. Each 
participant gave written informed consent. 
Participants 
We enrolled 7 patients with the clinical diagnosis of LVNC based on 
either echocardiographic or CMR documentation of a distinct two layered 
appearance of trabeculated and compacted myocardium. An arbitrary 
threshold for the degree of non-compaction was not applied so as not to 
exclude patients with a partial expression of the disease (Sasse-Klaassen et 
al., 2004). The imaging findings had to be accompanied by one of the 
following to increase the pre-test probability for this diagnosis: documentation 
of a similar appearance in first degree relatives suggestive of autosomal 
dominant transmission, associated neuromuscular disorders, or 
complications, such as systemic embolization and regional wall motion 
abnormalities (Table 7.1). The remaining subjects were healthy volunteers 
without a history of cardiovascular symptoms or risk factors, or drawn from 
groups giving a potential differential diagnosis for LVNC: 25 competitive 
athletes, 14 patients with dilated cardiomyopathy (DCM), 39 with hypertrophic 
cardiomyopathy (HCM), 17 with left ventricular hypertrophy secondary to 
hypertension, and 30 with aortic stenosis.
  
Table 7.1: Characteristics of patients diagnosed with left ventricular non-compaction (LVNC). 
LVNC 
patients 
Age 
(years) 
Gender symptoms FH ECG 
changes 
Regional 
wall motion 
abnormality 
LV EF 
(%) 
Neuro-
muscular 
findings 
NC/C 
ratio 
N of segments 
with NC 
1 14 M Heart failure as 
baby 
+ + — 48 — 2.4 12 
2 15 F — + + — 64 — 1.1 9 
3 38 M — + — — 61 — 2.3 8 
4 41 M — + — + 53 — 3.3 12 
5 46 M Systemic 
embolus 
—  + 17 — 6.1 15 
6 26 F — — — + 68 — 2.9 9 
7 25 M syncope — + + 59 + 2.7 8 
FH=family history; LVEF=left ventricular ejection fraction; NC=non-compaction;
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High-level competitive athletes, with an average of 19±7 hours training 
per week were recruited. HCM patients were diagnosed based on family 
history, and standard electrocardiographic and echocardiographic criteria in 
the absence of a secondary cause for cardiac hypertrophy. The diagnosis of 
DCM was based on impaired global left ventricular function, with an ejection 
fraction of less than 40% on echocardiography, and exclusion of other causes 
of LV dysfunction. Hypertensive and aortic stenosis patients were enrolled if 
they showed an end-diastolic wall thickness of greater than 13 mm on 
echocardiography.  
MR Imaging 
Steady-state free precession cine images were acquired in 3 long-axis 
views (i.e. horizontal and vertical long axis and left ventricular outflow tract), 
planned on short axis (SA) pilots at 60˚ angles to each other to visualize all 17 
segments according to the AHA recommendation (see also chapter 2 for 
details) (Cerqueira et al., 2002). 
Data Analysis 
Cine images were analyzed with CMRtools (Imperial College, London, 
UK), the observer being blinded to the diagnosis. The distribution of non-
compaction was assessed by qualitative analysis of all 17 segments for 
presence or absence of any degree of non-compaction, i.e. for a distinct two-
layered appearance of trabeculated and compacted myocardium. A segment 
was regarded as non-compacted, if the visual appearance clearly suggested 
the presence of two myocardial layers with different degrees of tissue 
compaction. In each of the three diastolic long axis views the segment with 
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the most pronounced trabeculations was chosen for measurement of the 
thickness of the non-compacted and the compacted myocardium 
perpendicular to the compacted myocardium. The ratio of non-compacted to 
compacted myocardium (NC/C ratio) in diastole was calculated for each of the 
three long axis views and only the maximal ratio was then used for analysis. 
The apex (segment 17) was excluded from the measurements, since the 
compacted myocardium is generally thinner in this area, and inclusion would 
have led to artificially high ratios.  
Statistical Analysis 
All data are presented as mean±standard deviation. Nominal data were tested 
using the Chi-square test. Continuous data were analyzed using ANOVA with 
post-hoc Bonferroni analysis to establish differences between LVNC and the 
six remaining groups individually. A p-value of less than 0.05 (after Bonferroni 
adjustment) was considered statistically significant. We used receiver 
operating characteristics (ROC) to generate cut-off values for optimized 
sensitivity and specificity to distinguish LVNC from all other groups of 
subjects.  
7.3 Results 
Non-compaction was more common in the apical segments of the 
healthy volunteers, being found in 91% of subjects, as compared to the mid-
cavity levels (78%), and the basal segments (21%, Figure 7.1). Non-
compaction was most common in the anterior segment, becoming less 
frequent in successive segments as viewed in a clockwise direction. Similar 
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patterns of distribution were seen in hearts of the patients with confirmed 
LVNC and in the other groups (Figure 7.1). Overall, patients with pathological 
non-compaction had involvement of significantly (p<0.01) more myocardial 
segments (10±3 segments) than did healthy volunteers (6±3 segments), 
athletes (6±4 segments), patients with hypertrophic (5±4 segments) and 
dilated cardiomyopathy (7±3 segments), and those with LV hypertrophy 
secondary to hypertension (4±4 segments) and aortic stenosis (6±4 
segments).
Chapter 7 128 D.Phil. thesis: S.E. Petersen 
 
0 20 40 60 80 100
 AH
Athletes n=25
0 20 40 60 80 100
 DCM
Dilated cardiomyopathy n=14
anterior basal
anteroseptal basal
inferoseptal basal
inferior basal
inferolateral basal
anterolateral basal
anterior mid-cavity
anteroseptal mid-cavity
inferoseptal mid-cavity
inferior mid-cavity
inferolateral mid-cavity
anterolateral mid-cavity
anterior apical
septal apical
inferior apical
lateral apical
Apex
0 20 40 60 80 100
 NV
Healthy volunteers n=45
anterior basal
anteroseptal basal
inferoseptal basal
inferior basal
inferolateral basal
anterolateral basal
anterior mid-cavity
anteroseptal mid-cavity
inferoseptal mid-cavity
inferior mid-cavity
inferolateral mid-cavity
anterolateral mid-cavity
anterior apical
septal apical
inferior apical
lateral apical
Apex
0 20 40 60 80 100
 HCM
Hypertrophic cardiomyopathy n=39
anterior basal
anteroseptal basal
inferoseptal basal
inferior basal
inferolateral basal
anterolateral basal
anterior mid-cavity
anteroseptal mid-cavity
inferoseptal mid-cavity
inferior mid-cavity
inferolateral mid-cavity
anterolateral mid-cavity
anterior apical
septal apical
inferior apical
lateral apical
Apex
0 20 40 60 80 100
Hypertensive heart disease n=17
0 20 40 60 80 100
% subjects with non-compaction
 AS
Aortic stenosis n=30
anterior basal
anteroseptal basal
inferoseptal basal
inferior basal
inferolateral basal
anterolateral basal
anterior mid-cavity
anteroseptal mid-cavity
inferoseptal mid-cavity
inferior mid-cavity
inferolateral mid-cavity
anterolateral mid-cavity
anterior apical
septal apical
inferior apical
lateral apical
Apex
0 20 40 60 80 100
% subjects with non-compaction
Left ventricular non-compaction n=7
 
Figure 7.1: Distribution of non-compaction. The bars represent the 
percentage of subjects in each group with non-compaction in given segments. 
The pattern of distribution of non-compaction does not separate the groups. 
Chapter 7 129 D.Phil. thesis: S.E. Petersen 
 
The end-diastolic NC/C ratio was, on average, at least 60% greater in 
patients with LVNC (3.0 ±1.5) compared to all other groups (p<0.01 for all, 
Figure 7.2). ROC analysis identified the end-diastolic NC/C ratio as a 
valuable parameter to distinguish pathological non-compaction from the 
lesser degrees of non-compaction encountered in healthy, dilated and 
hypertrophied hearts. A NC/C ratio of greater than 2.3 in diastole 
distinguished pathological non-compaction, with values for sensitivity, 
specificity, positive, and negative predictions of 86%, 99%, 75% and 99%, 
respectively. 
 
NC/C ratio
543210
Athlete’s heart (n=25)
Healthy volunteers (n=45)
HCM (n=39)
DCM (n=14)
Hypertension (n=17)
Aortic stenosis (n=30)
LVNC (n=7) **
N /  ti
 
Figure 7.2: Ratio of the end-diastolic thickness of the non-compacted and 
compacted layers of the myocardium (NC/C ratio). Data are presented as 
means (square) and 95% confidence interval (whiskers). ** denotes p<0.01.  
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7.4 Discussion 
We found that a degree of non-compaction of the left ventricle was far 
more frequent in healthy, dilated, and hypertrophied hearts than previously 
reported in cardiac imaging studies; presumably this is a manifestation of the 
increased sensitivity of CMR. Nevertheless, we have shown that the ratio 
between the trabecular and compact layers of the myocardium as measured 
by CMR in diastole is accurate in detecting pathological LVNC.  
The segmental distribution of non-compaction was similar in healthy, 
dilated, and hypertrophied hearts to that found in the patients with confirmed 
LVNC. However, the ratio between the myocardial thicknesses was at least 
60% greater in those with LVNC. We are, therefore, unable to lend support to 
the recent suggestion that the segmental distribution can be used to clarify 
the diagnosis of LVNC (Oechslin et al., 2000; Jenni et al., 2001). 
The trabecular layer of the developing ventricular walls is known to 
compact during its development from base to apex, from epi- to endocardium, 
and from the septal to the lateral wall (Sedmera et al., 2000). Although the 
underlying pathophysiological mechanisms for lack of such compaction 
remain unresolved, varying degrees of arrest of this normal embryological 
process (Jenni et al., 2001) provide an attractive explanation for the typical 
pattern of distribution seen in all our subjects. Almost 70% of autopsied 
healthy hearts are reported to show some degree of non-compaction (Boyd et 
al., 1987), a finding endorsed by the prevalence observed in our study, and 
probably one with no prognostic relevance. Partial expression of pathological 
LVNC is illustrated by one patient (patient 2, Table 7.1, Figure 7.3) who has 
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only mild anatomical non-compaction, but supporting evidence for this 
diagnosis. This phenomenon is typical of autosomal dominant conditions and, 
has recently been reported in large families with autosomal dominant LVNC 
(Sasse-Klaassen et al., 2004). 
I:2I:1
II:2II:1
 
Figure 7.3: The autosomal dominant pattern of inheritance in a family with 
pathological left ventricular non-compaction. Diastolic horizontal long axis 
views of parents (I:1 father and I:2 mother) and children (II:1-II.2) show 
variable degrees of non-compaction (black dotted arrows) in I:1 (patient 3, 
Table 7.1), II:1 (patient 2, Table 7.1) and II:2 (patient 1, Table 7.1). Patient II:1 
likely illustrates partial expression of pathological non-compaction, as her ratio 
of end-diastolic thicknesses is less than 2.3 (1.1). 
Previous case studies using CMR imaging have usually considered 
echocardiographic criteria to represent the gold standard for diagnosis. One 
small study, mainly using older gradient echo sequences, suggested 
echocardiography to be superior to CMR at that time (Weiss et al., 2003). 
Advances in CMR have resulted in superior image quality. We used diastolic 
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steady-state free precession cine frames to determine the ratio of thickness of 
the trabecular and compact layers, the trabeculations being more easily 
identified by CMR in the relaxed heart. The diastolic ratio of greater than 2.3 
showed high diagnostic accuracy for distinguishing pathological LVNC from 
the degrees of non-compaction observed in healthy, dilated, and 
hypertrophied hearts. This slightly higher cut-off value reflects that the 
measurement obtained with CMR is taken in diastole, while the 
echocardiographic values are taken in systole (cut-off value of 2.0) (Jenni et 
al., 2001).  
Limitations 
The main limitation of our study is the relatively small number of 
patients with features of LVNC in whom the diagnosis could be confirmed by 
the presence of other abnormalities. Isolated echocardiographic or CMR 
evidence of marked non-compaction was intentionally not considered 
sufficient for inclusion so as to avoid circular reasoning.  
Conclusions 
Based on the ratio of end-diastolic thickness of the non-compacted and 
compacted layers of the myocardium, we have shown that cardiovascular 
magnetic resonance imaging is accurate when diagnosing pathological left 
ventricular non-compaction. We propose that measurements are best made in 
diastole and that the cut-off values should be different from those used in 
echocardiography. Our findings support the clinical use of CMR in diagnosing 
LVNC, especially for those patients with poor echocardiographic windows.
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CHAPTER 8: Derangement of cardiac high-energy phosphate 
metabolism in patients with left ventricular non-compaction 
and preserved ejection fraction 
8.1 Introduction 
Left ventricular non-compaction is characterised by the presence of an 
extensive non-compacted layer of myocardium, which can lead to malignant 
arrhythmias, thromboembolism and chronic cardiac failure (Chin et al., 1990; 
Ritter et al., 1997; Ichida et al., 1999; Oechslin et al., 2000; Stollberger et al., 
2002). Raised awareness of the condition, coupled with improved diagnostic 
tools, such as contrast echocardiography and cardiovascular magnetic 
resonance imaging (Koo et al., 2002; Petersen et al., 2005), and emerging 
evidence of frequent autosomal dominant transmission (Sasse-Klaassen et 
al., 2003; Sasse-Klaassen et al., 2004), now lead to earlier diagnosis, even in 
patients who are asymptomatic. The non-compacted myocardial layer likely 
represents an arrest during development of normal compaction (Sedmera et 
al., 2000), albeit that the pathophysiological mechanisms leading to cardiac 
failure remain unknown. It is also unknown as to why some patients do, whilst 
others do not, develop cardiac failure. 
One attractive mechanism which may underlie the progression into 
cardiac dysfunction may be altered metabolism of cardiac high-energy 
phosphates, since similar changes have been described in patients with 
hypertrophic (Jung et al., 1998; Crilley et al., 2003) or dilated cardiomyopathy 
(Neubauer et al., 1992; Beer et al., 2002). If this was the case, there would be 
two clinical implications: First, it would suggest treatment strategies aimed at 
improving myocardial energetics. Second, altered cardiac energetics may 
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potentially serve to distinguish patients with non-compaction at low and high 
risk of developing complications, analogous to the situation in dilated 
cardiomyopathy, where energetic impairment has been shown to be a 
powerful predictor of prognosis (Neubauer et al., 1997a). Thus, we aimed to 
investigate cardiac energy metabolism in a group of patients with preserved 
cardiac function in the setting of ventricular non-compaction. 
8.2 Methods 
Study Population 
We studied 7 patients, 5 of male gender, with clear evidence of left 
ventricular non-compaction on cardiac magnetic resonance imaging, as 
defined by a ratio of non-compacted to compacted myocardium during 
diastole of greater than 2.3, or a distinct two-layered appearance of 
trabeculated and compacted myocardium with strong supporting clinical 
findings, such as electrocardiographic changes, as encountered in 2 of our 
patients with negative T waves, or family history, positive in 6 of the patients 
(Petersen et al., 2005). Of the 7 patients, 3 had been included in our previous 
publication describing the diagnostic accuracy of magnetic resonance imaging 
(Petersen et al., 2005). We were treating 2 patients with betablockers. We 
selected 7 age- and sex-matched healthy volunteers as controls. We 
excluded from the study any patients with contraindications for magnetic 
resonance imaging, or any with left ventricular ejection fractions of less than 
50% as judged by magnetic resonance imaging. The study was carried out 
according to the principles of the Declaration of Helsinki, and was approved 
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by our institutional ethics committee. Each subject gave informed written 
consent. 
Cardiovascular Magnetic Resonance Imaging and Spectroscopy Protocol 
Steady-state free precession cine images (SSFP) and 31P-MRS were 
acquired as outlined in detail in chapter 2.  
Image and Spectroscopy Analysis 
The diastolic ratio of non-compacted to compacted myocardium (NC/C 
ratio) was measured as described in chapter 7. 
Analysis of SSFP cine images was performed with Argus software 
(Version 2002B, Siemens Medical Solutions, Erlangen, Germany), as outlined 
in chapter 2.  
Cardiac high-energy phosphate metabolites (blood and T1 corrected 
PCr/ATP ratio, an index of the energetic state of the heart) were measured at 
rest using 31P-MR spectroscopy in the compacted basal anterior myocardium 
as outlined in chapter 2. In extensive preliminary studies, we attempted to 
measure PCr/ATP ratios in non-compacted apical myocardium, but this was 
not feasible due to insufficient signal-to-noise.  
Statistical Analysis 
All data are presented as means plus or minus standard deviations 
(SD), unless stated otherwise. Independent t-tests were used to test for 
differences between controls and those with non-compaction. Pearson’s 
correlation analysis was performed for the end-diastolic volume of the left 
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ventricle, and the ratio of PCr to ATP. Throughout the analyses, a two-sided 
p-value of <0.05 was considered statistically significant. All computations 
were performed with SPSS 11.5 (SPSS Inc., Chicago, US).  
8.3 Results 
The mean ratio of the non-compacted to compacted myocardial layers 
during diastole in the patients diagnosed with non-compaction was 2.6 ± 0.9, 
with a range from 1.1 to 4.0. All the patients, on the basis of our criteria for 
inclusion, had preserved left ventricular ejection fractions and, which were 
measured at 68 ± 5, not significantly different from the values of 72 ± 4 in the 
control subjects (p=0.16, Table 8.1). There were no abnormalities of regional 
wall motion in any of the subjects. Compared to the controls, however, the 
patients with non-compaction had significantly dilated left ventricles, with both 
end-diastolic (146 ± 33 vs. 116 ± 16 ml, p=0.049) and end-systolic (46 ± 11 
vs. 33 ± 8 ml, p=0.019) volumes increased compared to the control values 
(Figure 8.1). Figure 8.2 shows typical 31P-magnetic resonance spectra of a 
healthy volunteer and a patient with non-compaction with a decrease of the 
ratio of PCr to ATP in the patient. Individual and mean ratios are given in 
Figure 8.3. The ratio was significantly reduced by 19% in those with non-
compaction compared to their controls (1.81 ± 0.10 vs. 2.25 ± 0.36, p=0.005). 
Furthermore, the ratio did not correlate significantly (p=0.32) with left 
ventricular volumes, suggesting that the cavity dilation, which leads to 
increased wall stress, is not related to the derangement in cardiac energetics. 
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Table 8.1: Baseline characteristics of healthy controls and patients with left 
ventricular non-compaction (LVNC). 
 
 Healthy control (n=7) LVNC (n=7) 
P 
value
Age (years) 39±13 37±16 0.79 
Gender 5 male/ 2 female 5 male/ 2 female N/A 
BSA (m2) 2.02±0.20 1.82±0.23 0.11 
Mean blood pressure 
(mmHg) 98±12 100±10 0.72 
Family history of LVNC 0 6 (86%) NA 
ECG changes 0 2 (29%) NA 
Heart rate (bpm) 68±13 66±12 0.74 
LV ejection fraction (%) 72±4 68±5 0.16 
LV stroke volume (ml) 83±12 100±27 0.16 
LV mass (g) 99±15 105±32 0.67 
Values are presented as mean ± standard deviation. BMI = body mass index, BSA = body 
surface area, LV = left ventricle/ventricular. NA = not applicable 
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Figure 8.1: Increased left ventricular end-diastolic (LVEDV) and end-systolic 
(LVESV) volumes in patients with left ventricular non-compaction (LVNC, 
black bars) and preserved systolic LV function compared to healthy controls 
(white bars). 
LVNCHealthy volunteer
PCr ATP
γ
α
β
PCr
ATP
γ
α
β
ppm ppm
10        5         0        -5      -10       -15    10        5         0        -5      -10       -15    
 
Figure 8.2: Typical spectra of a healthy volunteer (A) and a patient with left 
ventricular non-compaction (LVNC) and preserved systolic LV function (B). 
Please note the substantially reduced PCr/ATP ratio in LVNC. 
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Figure 8.3: Reduced PCr/ATP ratio in patients with left ventricular non-
compaction (LVNC) compared to healthy controls. Dots represent individual 
PCr/ATP ratios and square and whiskers the mean ± standard deviation. 
8.4 Discussion 
To the best of our knowledge, ours is the first study to show that levels 
of high-energy phosphates are reduced in the myocardium of patients with left 
ventricular non-compaction and maintained left ventricular systolic function. 
Our demonstrated reduction in the ratio of PCr to ATP by almost one-fifth is 
similar to those described in asymptomatic patients with hypertrophic 
cardiomyopathy, where reductions of one-quarter have been shown (Jung et 
al., 1998), and in genotyped patients with and without hypertrophy, with 
reductions shown of up to three-tenths (Crilley et al., 2003). In hypertrophic 
cardiomyopathy, the deranged cardiac energetics are considered to be 
intrinsic rather than secondary, in other words the consequence of reduced 
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perfusion or fibrosis. This hypothesis is supported by the identification of a 
primary metabolic mutation in AMP-activated protein kinase, a major regulator 
of energy metabolism, leading to a hypertrophic cardiomyopathic phenotype 
(Blair et al., 2001). Reduced ratios in dilated cardiomyopathy are again of 
similar magnitude to that found in our study, being decreased by one-quarter 
(Beer et al., 2002). Interestingly, we found reduced ratios despite preservation 
of left ventricular ejection fractions, a finding which has previously been 
described in patients with Becker muscular dystrophy and their female 
carriers (Crilley et al., 2000), as well as in patients with type 2 diabetes 
mellitus (Scheuermann-Freestone et al., 2003). The authors of these studies 
concluded that the depletion of cardiac energy occurred early in the process 
of the disease, and may have contributed to the development of cardiac 
contractile failure. Thus, such deranged mechanisms of cardiac energy in 
patients with non-compaction may also precede the development of cardiac 
contractile dysfunction. These findings may have important clinical 
implications, as energy sparing medications, such as betablockers, may help 
to prevent or improve the development of chronic heart failure in the patients 
with non-compaction, while energy costly drugs, such as beta-agonists, might 
prove detrimental. These hypotheses remain to be tested, but a small study in 
six patients with dilated cardiomyopathy studied before and after treatment of 
cardiac failure showed an increase in the ratio of PCr to ATP at three months 
follow-up compared to baseline (Neubauer et al., 1992). 
High contrast imaging modalities now permit allow early diagnosis of 
non-compaction as an incidental finding in asymptomatic patients. For such 
patients, there is currently no consensus on strategies for treatment. 
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Measuring the ratio of PCr to ATP could well serve as a discriminator of a 
benign as opposed to a malignant course, as was shown in dilated 
cardiomyopathy (Neubauer et al., 1997a). Such a prognostic value also needs 
to be investigated in long-term follow-up studies. 
While we have demonstrated reduced ratios of PCr to ATP in patients 
with left ventricular non-compaction, our data do not allow us to identify the 
molecular mechanisms that lead to the intrinsic metabolic derangements in 
cardiac energetics. Future studies are needed to investigate these molecular 
mechanisms.  
Conclusions 
In summary, the metabolism of high-energy phosphate is deranged in 
the non-compacted left ventricular myocardium of patients with maintained 
ejection fractions. The most likely mechanism is an intrinsic derangement of 
cardiac energetics. Our data suggest a new mechanism leading to 
development of chronic heart failure in such patients, and provide a potential 
target for therapeutic strategies. Future long-term follow-up studies are 
needed to test whether the deranged metabolism may have prognostic value. 
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CHAPTER 9: General conclusions and outlook 
We have produced a large database for left and right ventricular and 
left atrial volumes of healthy volunteers using SSFP cine images and three-
dimensional, endo- and epicardial, systolic and diastolic myocardial velocities 
using tissue phase mapping. This will be of particular use for reference in both 
clinical and research studies. We found further evidence for the benign nature 
of athlete’s hearts and were able to provide MR-specific diagnostic criteria for 
the differentiation of physiological from pathological LV hypertrophy. Left 
ventricular non-compaction can be diagnosed accurately by magnetic 
resonance imaging and we identified an altered cardiac energy metabolism as 
a potential contributing factor towards progression into heart failure in such 
patients. This novel mechanism may present a potential target for treatment 
strategies. 
Building on the cardiovascular magnetic imaging and spectroscopy 
protocol developed here, we are now planning to extend the work presented 
in this thesis, incorporating additional MR measurements of absolute 
perfusion at rest and stress, as well as measuring the extent of myocardial 
regional fibrosis by contrast-enhanced MRI. Cardiac PCr and ATP 
concentrations at rest in three groups of patients with HCM phenocopies due 
to known mutations where there is uncertainty about the involvement of 
myocardial energetics will be investigated: Anderson Fabry disease, 
Noonan’s syndrome and patients with PRKAG2 mutations. The metabolic 
data will be analysed for regional differences and will be correlated to regional 
variations in wall thickness, wall thickening, tissue contractility, absolute 
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perfusion at rest and stress, and to the extent of regional fibrosis. These 
studies should allow us to determine whether these genetically unrelated 
conditions share aspects of pathogenesis, and are thus informative for 
understanding hypertrophic cardiomyopathy disease mechanisms, or are 
indeed only superficially similar. 
Such CMR imaging and MRS protocol can also be applied to patients 
with hypertrophic cardiomyopathy to investigate whether the energetic deficit 
is a primary phenomenon, or whether it is explained by myocardial fibrosis or 
by altered perfusion. 
Last but not least, we plan to establish a substantial database of CMR 
imaging and spectroscopy parameters in genotyped hypertrophic 
cardiomyopathy patients to allow novel insights into genotype-phenotype 
correlations. 
We predict that CMR will become the central modality for the 
characterisation of the remodelled heart, both in research and in clinical 
practice.
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Figure 2.1: Standardized myocardial 17 segment model (segment 
number given in brackets) and nomenclature for 
tomographic imaging of the heart: Adapted from a 
statement for healthcare professionals from the 
Cardiac Imaging Committee of the Council on Clinical 
Cardiology of the American Heart (Cerqueira et al., 
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Figure 2.2: End-diastolic short-axis images from base to apex in a 
healthy volunteer with endocardial and epicardial 
contours drawn for both the left and right ventricles. 
The basal slice was selected for the left ventricle 
when at least fifty percent of the blood volume was 
surrounded by myocardium in both end-diastole and 
end-systole. The apical slice was defined as the last 
slice showing intracavity blood pool. For the right 
ventricle, volumes below the pulmonary valve were 
included. From the inflow tract, RV volumes were 
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trabeculated, suggestive of right atrium. Papillary 
muscles were included in the LV mass.....................................46 
Figure 3.1: Horizontal long axis (HLA) in end-diastole (A) and 
end-systole (B), vertical long axis (VLA) in end-
diastole (C) and end-systole (D) illustrating contouring 
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Figure 3.2: Interstudy reproducibility for LV ejection fraction (LV 
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ejection fraction (LA EF) for 12 healthy volunteers 
(Bland-Altman plot (Bland and Altman, 1986)). Solid 
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cubic Hermite interpolation. Panels A, D and G show 
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velocities expansion. Panels B, E and H display 
circumferential velocities (n=96) with positive 
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positive velocities indicating base movement away 
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The base of the heart undergoes an initial 
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velocity directed towards the apex occurs (3) before 
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early diastole (4). This is followed by a rapid decrease 
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Figure 4.3: Segmental and myocardial layer distribution of radial 
velocity parameters (n=96). Segments 1-6 are basal, 
7-12 mid-ventricular and 13-16 apical according to the 
AHA/ACC recommendation (Cerqueira et al., 2002). 
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velocity parameters are shown as mean ± standard 
error of the mean. Positive radial velocities indicate 
contraction and negative radial velocities expansion. 
Transmural gradients for systolic and diastolic peak 
radial velocities are observed in each of the three 
myocardial levels (p<0.001 for both) with higher 
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mid-ventricular and apical slices were located at 28 ± 
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during the cardiac cycle at mid-ventricular level shown 
as the mean for the first 18 consecutive healthy 
volunteers. Observer 1, measurement 1 (solid line), 
observer 1, measurement 2 (dashed-dotted line), 
observer 2 (dashed line) and second scan (dotted 
line). Note the small variation in systolic and diastolic 
peak velocities and systolic and diastolic time to peak 
velocities. ED=end-diastole, ES=end-systole. ..........................80 
Figure 5.1: End-diastolic still frames of steady-state free 
precession cines in a male sedentary control (A: Body 
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